{"study_id": 105644, "supplement_id": 863, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the long-term safety of entecavir, focusing on adverse events potentially associated with nucleos(t)ide analogs, including effects on alanine aminotransferase (ALT) levels.", "results_summary": "Long-term entecavir administration showed low rates of serious adverse events (AEs), discontinuations due to AEs, and ALT flares. Most AEs were mild to moderate, with infrequent occurrences of nucleos(t)ide-associated AEs like myalgia and neuropathy.", "population_specificity": "Chronic hepatitis B patients previously treated with entecavir, lamivudine, or adefovir monotherapy.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Median exposure was 184 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:54.099029+00:00"}
{"study_id": 105647, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the biochemical properties of AGT allelic forms and PH1-causing variants to understand the molecular basis of PH1 pathogenesis and predict treatment responses.", "results_summary": "The study highlights the effects of pathogenic mutations on AGT protein function, improving understanding of PH1 pathogenesis and aiding in predicting pyridoxine treatment responses or suggesting new therapeutic strategies.", "population_specificity": "Patients with Primary Hyperoxaluria Type 1 (PH1) caused by AGXT gene mutations.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:54.219103+00:00"}
{"study_id": 105646, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers compared the effectiveness of lamivudine (LAM) and entecavir (ETV) in treating acute exacerbation of chronic hepatitis B with elevated alanine aminotransferase (ALT) levels.", "results_summary": "Both LAM and ETV showed high initial virological response rates (83.3% and 100%, respectively), with no significant reduction in HBV DNA after 1 or 3 months. ETV-treated patients did not require drug changes, unlike 41.6% of LAM-treated patients who developed resistance.", "population_specificity": "Patients with acute exacerbation of chronic hepatitis B and ALT levels \u2265500 IU/L.", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:54.812520+00:00"}
{"study_id": 105648, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the effectiveness of the American Thoracic Society risk-factor approach versus uniform liver function testing at 2 weeks for predicting drug-induced liver injury in tuberculosis patients.", "results_summary": "The study found that the American Thoracic Society algorithm had limited sensitivity and specificity for predicting drug-induced liver injury, while uniform liver function testing at 2 weeks was more specific but less sensitive for late injury. Early drug-induced liver injury was more common in HIV-infected individuals.", "population_specificity": "Adult patients undergoing therapy for active tuberculosis at a tertiary center, including a significant proportion with HIV infection.", "effective_dosage": "Not specified", "study_duration": "Liver function was monitored at baseline and 2 weeks after therapy commencement.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:56.858200+00:00"}
{"study_id": 105649, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to evaluate the efficacy and safety of vatalanib in untreated malignant mesothelioma patients, not specifically Alanine.", "results_summary": "Elevated alanine aminotransferase (11%) was noted as a grade 3/4 adverse event, but the study did not focus on Alanine's effects.", "population_specificity": "Previously untreated patients with malignant mesothelioma (median age 75, 79% ECOG performance status 1).", "effective_dosage": "Not applicable (study focused on vatalanib, not Alanine).", "study_duration": "Not applicable (study focused on vatalanib, not Alanine).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:57.203611+00:00"}
{"study_id": 105650, "supplement_id": 863, "safety_score": "30", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to reassess causality levels between Greater Celandine (GC) use and liver injury, focusing on alanine aminotransferase changes and confounding variables.", "results_summary": "The study found that GC hepatotoxicity was highly probable or probable in 8 out of 21 cases, with the remaining cases showing lower causality. The reaction was identified as idiosyncratic metabolic, lacking immunologic or obligatory hepatotoxic features.", "population_specificity": "Patients with reported liver injury linked to Greater Celandine use (21 cases).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:57.559607+00:00"}
{"study_id": 105652, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to identify risk factors for hepatocellular carcinoma (HCC) in patients with autoimmune hepatitis (AIH), focusing on the role of abnormal alanine aminotransferase (ALT) levels.", "results_summary": "The study found that abnormal ALT at final observation was an independent risk factor for HCC development in AIH patients, alongside cirrhosis at diagnosis. Normalizing ALT was emphasized as important for reducing HCC risk.", "population_specificity": "180 patients diagnosed with AIH in Japan (159 female, 21 male; mean age 59.9 years).", "effective_dosage": "Not specified", "study_duration": "Mean observation period of 80.2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:01.449164+00:00"}
{"study_id": 105651, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether genetic variations, including those affecting alanine (specifically the SLCO1B1 rs4149056 SNP involving a valine-for-alanine substitution), influence LDL cholesterol lowering with pravastatin.", "results_summary": "The study found that the rs4149056 SNP (valine for alanine at position 174 in SLCO1B1) was associated with significantly reduced LDL cholesterol lowering response to pravastatin, while the rs2306283 SNP (asparagine for aspartic acid at position 130) showed no effect.", "population_specificity": "5,411 elderly participants (mean age 75.3 years) at risk for cardiovascular disease.", "effective_dosage": "Pravastatin 40 mg/day.", "study_duration": "Mean follow-up of 3.2 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:02.397273+00:00"}
{"study_id": 105654, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to examine the effects of vitamin D supplementation on inflammatory biomarkers, including alanine aminotransferase (ALT), in overweight and obese adults undergoing resistance exercise training.", "results_summary": "The study found no significant changes in circulating ALT levels after 12 weeks of vitamin D supplementation combined with resistance training, indicating no effect on this biomarker.", "population_specificity": "Overweight and obese adults (BMI 31.3 \u00b1 3.2 kg/m\u00b2, aged 26.1 \u00b1 4.7 years).", "effective_dosage": "Not applicable (study focused on vitamin D, not alanine dosage).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:02.737623+00:00"}
{"study_id": 105653, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of adipose tissue insulin resistance in metabolic and histological abnormalities in obese patients with NAFLD, including the relationship with alanine aminotransferase levels.", "results_summary": "The study found that patients with NAFLD had higher plasma alanine aminotransferase levels compared to controls, indicating liver dysfunction, and these levels worsened with increasing adipose tissue insulin resistance. However, the abstract does not specifically evaluate alanine's effects as a supplement or therapeutic agent.", "population_specificity": "207 obese patients with NAFLD (BMI = 34.1 \u00b1 0.3 kg/m\u00b2) and 22 controls without NAFLD.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:02.766648+00:00"}
{"study_id": 105656, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not focus on Alanine but rather on the development and approval of crizotinib for ALK-rearranged NSCLC.", "results_summary": "The study does not report any findings related to Alanine.", "population_specificity": "ALK-rearranged NSCLC patients.", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:02.794577+00:00"}
{"study_id": 105655, "supplement_id": 863, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to examine the efficacy and tolerability of PEG-IFN-\u03b12A in chronic hepatitis B (CHB) patients in a clinical setting, focusing on outcomes like ALT normalization, viral suppression, and HBeAg seroconversion.", "results_summary": "The study found that PEG-IFN-\u03b12A was well tolerated, with 6.5% discontinuing due to adverse events. Efficacy varied: 46% of HBeAg-positive patients achieved ALT normalization, 16% had viral loads <351 IU/mL, and 32% achieved HBeAg seroconversion; HBeAg-negative patients showed 55% ALT normalization and 36% viral suppression.", "population_specificity": "Chronic hepatitis B patients (HBeAg-positive and HBeAg-negative), predominantly male and of Asian origin, treated at tertiary hospitals.", "effective_dosage": "180\u00b5g/week", "study_duration": "48 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:05.111705+00:00"}
{"study_id": 105657, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the beneficial and harmful effects of interferon alpha for patients with chronic hepatitis D, including its impact on virologic, biochemical, and histological responses.", "results_summary": "Interferon alpha showed some efficacy in suppressing viral and liver disease activity, but the benefits were not sustained in most patients. Adverse events were common and sometimes severe, with no significant histological improvement observed.", "population_specificity": "Patients with chronic hepatitis D infection (201 participants, predominantly male).", "effective_dosage": "Higher and lower doses of interferon alpha were compared, but specific amounts and frequencies are not detailed in the abstract.", "study_duration": "Follow-up included end of treatment and six months or more post-treatment, but exact intervention duration is not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:05.740489+00:00"}
{"study_id": 105658, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 48, "quality_score": 75, "study_goal": "The researchers aimed to compare the therapeutic efficacy of Peg-IFN alfa-2a and Peg-IFN alfa-2b with ribavirin in treating chronic hepatitis C (CHC) patients with HCV genotype 1b, focusing on virological and biochemical responses, including alanine transaminase (ALT) levels.", "results_summary": "The study found that both Peg-IFN alfa-2a and Peg-IFN alfa-2b with ribavirin significantly reduced HCV-RNA and ALT levels, with no significant differences between the two treatments. Sustained virological response (SVR) was achieved in 48.3% and 44.3% of patients, respectively.", "population_specificity": "260 adult patients with chronic hepatitis C and HCV genotype 1b from the south of Poland.", "effective_dosage": "Not specified (Peg-IFN alfa-2a or Peg-IFN alfa-2b with ribavirin for 48 weeks).", "study_duration": "48 weeks of therapy, with follow-up at 72 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:08.517595+00:00"}
{"study_id": 105659, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not focus on Alanine; it evaluates the efficacy and safety of pitavastatin in clinical practice.", "results_summary": "The study does not report findings related to Alanine.", "population_specificity": "Japanese patients with hypercholesterolemia.", "effective_dosage": "Not mentioned (for Alanine).", "study_duration": "Not mentioned (for Alanine).", "interactions": "None mentioned (for Alanine).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:08.737314+00:00"}
{"study_id": 105661, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of thiadiazolidinone inhibitors targeting alanine racemase (Alr) as a therapeutic agent against MRSA.", "results_summary": "The thiadiazolidinone series effectively inhibited Alr activity (IC\u2085\u2080 0.36\u20136.4 \u03bcM) and showed antimicrobial activity against S. aureus, including MRSA strains (MICs 6.25\u2013100 \u03bcg/ml), but also inhibited human HeLa cell proliferation, indicating potential toxicity.", "population_specificity": "In vitro study targeting MRSA and human HeLa cells.", "effective_dosage": "IC\u2085\u2080 0.36\u20136.4 \u03bcM for enzyme inhibition; MICs 6.25\u2013100 \u03bcg/ml for bacterial growth inhibition.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:14.341702+00:00"}
{"study_id": 105660, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine if early lactate clearance could serve as an accurate predictor for initial poor graft function (IPGF) following liver transplantation, with a focus on alanine aminotransferase (ALT) levels as a marker.", "results_summary": "The study found that early lactate clearance was significantly higher in the non-IPGF group (43.2%) compared to the IPGF group (13.4%), with a cut-off value of 24.8% predicting IPGF with high sensitivity (95.5%) and specificity (88.9%). Patients with lactate clearance \u226424.8% had a 169-fold higher risk of IPGF and a 3.6-fold higher risk of in-hospital mortality.", "population_specificity": "222 patients referred to the surgical intensive care unit (SICU) after orthotopic liver transplantation.", "effective_dosage": "Not available", "study_duration": "Lactate levels were measured at SICU presentation (hour 0) and at hour 6 post-transplant.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:14.683521+00:00"}
{"study_id": 105666, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers investigated whether IL28B genotypes are associated with treatment response to peginterferon alfa (PEG-IFN) in HBeAg-positive chronic hepatitis B patients.", "results_summary": "IL28B genotypes were significantly associated with HBeAg seroconversion at the end of treatment and during long-term follow-up, as well as hepatitis B surface antigen clearance. Similar results were observed for both rs12980275 and rs12979860 polymorphisms.", "population_specificity": "HBeAg-positive chronic hepatitis B patients (205 participants from 11 European and Asian hospitals).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:14.924197+00:00"}
{"study_id": 105665, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the incidence, temporal trends, and clinical significance of liver enzyme elevations (including alanine transaminase, ALT) in patients with ST-segment elevation myocardial infarction (STEMI).", "results_summary": "Elevated ALT was common (48.2% of patients) and correlated with CK-MB levels. ALT elevations were independently associated with worse mortality and clinical outcomes, even after adjusting for CK-MB.", "population_specificity": "1903 patients with STEMI from two clinical trials.", "effective_dosage": "Not available", "study_duration": "Measurements taken at baseline, days 1, 6, and 14.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:15.134224+00:00"}
{"study_id": 105662, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and safety of IVMP+IVIG combination therapy for refractory Kawasaki disease (KD), using the Egami score (which includes alanine aminotransferase levels) to predict refractory cases.", "results_summary": "The study found that IVMP+IVIG therapy resulted in prompt defervescence in 86.4% of predicted refractory KD patients, compared to 23.1% with IVIG alone. No serious adverse events were reported in either group.", "population_specificity": "122 patients with Kawasaki disease, including 48 predicted to have refractory KD based on the Egami score.", "effective_dosage": "Not specified for alanine aminotransferase (used as a predictive marker, not a treatment).", "study_duration": "Not specified for alanine-related intervention.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:15.265439+00:00"}
{"study_id": 105663, "supplement_id": 863, "safety_score": "40", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety, pharmacokinetics, and antitumor activity of ispinesib, including its effects on alanine aminotransferase levels in patients with advanced breast cancer.", "results_summary": "The study found that increased alanine aminotransferase was a common toxicity (56%), with dose-limiting toxicity observed at 12 mg/m\u00b2. Disease stabilization occurred in 73.3% of patients, but antitumor activity was limited (7% response rate).", "population_specificity": "Patients with locally advanced or metastatic breast cancer who had received prior neoadjuvant or adjuvant chemotherapy.", "effective_dosage": "10 mg/m\u00b2 (n=3), 12 mg/m\u00b2 (n=6), and 14 mg/m\u00b2 (n=7), administered as a 1-hour infusion on days 1 and 15 every 28 days.", "study_duration": "Until toxicity or disease progression (exact duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:15.679623+00:00"}
{"study_id": 105668, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to compare serum biochemistry levels, including alanine aminotransferase (ALT), between breast-fed and formula-fed infants at 4 and 8 weeks of age.", "results_summary": "Serum ALT levels were significantly higher in breast-fed infants compared to formula-fed infants at both 4 and 8 weeks of age, indicating a metabolic difference influenced by nutrition source.", "population_specificity": "Healthy 4-week-old and 8-week-old infants (30 breast-fed, 30 formula-fed).", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:16.386923+00:00"}
{"study_id": 105667, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to compare the accuracy of transient elastography (TE) for assessing liver fibrosis in chronic HBV and HCV patients and evaluate the impact of alanine aminotransferase (ALT) levels on TE performance.", "results_summary": "TE showed comparable diagnostic accuracy for liver fibrosis in HBV and HCV patients, with no significant influence of ALT levels on TE performance in HBV individuals. ALT-specific cut-off values did not improve diagnostic performance for fibrosis prediction in HBV patients.", "population_specificity": "Treatment-na\u00efve patients with compensated chronic HBV or HCV infection.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:16.387590+00:00"}
{"study_id": 105671, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential benefits of antioxidant therapy, including Alanine, in managing liver diseases such as chronic hepatitis C, alcoholic liver disease, and NASH.", "results_summary": "The study found mixed results for antioxidant therapy, with the most promising outcomes for vitamin E in NASH and some encouraging results for acute alcoholic hepatitis. However, there was no convincing evidence that antioxidant therapy, including Alanine, significantly benefits chronic hepatitis C patients.", "population_specificity": "Patients with chronic hepatitis C, alcoholic liver disease, and non-alcoholic steatohepatitis (NASH).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:22.987644+00:00"}
{"study_id": 105670, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the potential of metadoxine (which includes alanine) as a pharmacotherapy for alcohol dependence, particularly in patients with alcoholic liver disease.", "results_summary": "The study found significant reductions in alcohol consumption, craving (measured by VAS), and improvements in liver-related biomarkers (AST/ALT ratio). A majority of patients (67.3%) achieved complete abstinence during follow-up.", "population_specificity": "94 outpatients with alcohol dependence, some with alcoholic liver disease.", "effective_dosage": "500-2000 mg/day (mean 1277 mg/day).", "study_duration": "2-42 days (mean 8.9 days).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:22.990655+00:00"}
{"study_id": 105672, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers evaluated the clinical impact of abnormal liver or muscle enzyme results, including alanine aminotransferase, in statin-treated patients.", "results_summary": "The study found that routine follow-up enzyme tests for statin-treated patients had little practical value, with treatment changes more likely in symptomatic patients, particularly those with musculoskeletal symptoms.", "population_specificity": "408 statin-treated patients (average age 63.8 \u00b1 10.9 years) with at least one enzyme level > 10% normal.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:23.107807+00:00"}
{"study_id": 105674, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to identify epitopes recognized by IgG in MS CSF, using alanine scan mutagenesis to analyze peptide binding specificity.", "results_summary": "The study identified peptides derived from proteins including serine/threonine-protein kinase, protein ZIP2, and MHC class II, recognized by OCBs in MS CSF, suggesting potential diagnostic and therapeutic targets. Alanine scan mutagenesis was used to confirm linear epitopes.", "population_specificity": "5 MS patients", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:23.190019+00:00"}
{"study_id": 105669, "supplement_id": 863, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the long-term efficacy and safety of adefovir dipivoxil (ADV) treatment in HBeAg-positive chronic hepatitis B (CHB) patients, focusing on virological, serological, and biochemical responses.", "results_summary": "Five years of ADV treatment led to sustained suppression of HBV DNA, increasing rates of undetectable HBV DNA (from 28% to 58%) and HBeAg seroconversion (from 11% to 29%), with maintained ALT normalization in 75-79% of subjects. Virological resistance occurred in 14.6% of patients, necessitating urgent switch or add-on therapy if detected.", "population_specificity": "Chinese subjects with HBeAg-positive chronic hepatitis B (CHB).", "effective_dosage": "10 mg daily.", "study_duration": "5 years (initial 1-year double-blind study followed by 208-week open-label continuation).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:24.137328+00:00"}
{"study_id": 105673, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether folic acid (FA) supplementation could reduce serum alanine aminotransferase (ALT) levels in hypertensive Chinese adults.", "results_summary": "The study found that a high dose of FA (0.8 mg) combined with enalapril significantly reduced ALT levels, particularly in men and participants with elevated baseline ALT (>40 IU/l), while the low FA dose showed no difference compared to the control group.", "population_specificity": "Hypertensive Chinese adults without known hepatic disease.", "effective_dosage": "0.4 mg FA (low dose) or 0.8 mg FA (high dose) combined with 10 mg enalapril, once daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:24.259215+00:00"}
{"study_id": 105676, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the long-term clinical effects of metreleptin on glycemic and lipid abnormalities, including markers of hepatic steatosis (ALT and AST), in patients with lipodystrophy.", "results_summary": "Metreleptin treatment led to sustained reductions in hemoglobin A1c, triglycerides, ALT, and AST levels over a 3-year period, with more pronounced improvements in patients with elevated baseline levels. Adverse events were likely linked to underlying metabolic conditions rather than the treatment itself.", "population_specificity": "55 patients (36 with generalized lipodystrophy, 19 with partial lipodystrophy) with metabolic abnormalities (diabetes, high triglycerides, or insulin resistance) and low leptin levels.", "effective_dosage": "Subcutaneous injections once or twice daily (specific dosage not provided).", "study_duration": "3 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:25.772058+00:00"}
{"study_id": 105675, "supplement_id": 863, "safety_score": "20", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the potential role of beta-N-methylamino-L-alanine (BMAA), a non-protein amino acid, as an environmental factor in neurodegenerative diseases like ALS.", "results_summary": "The study found that BMAA has toxic effects on motor neurons, including receptor agonism, oxidative stress induction, and glutathione depletion, and may contribute to protein misfolding, a hallmark of neurodegeneration. While an animal model for BMAA-induced ALS is lacking, substantial evidence supports a link between BMAA and ALS.", "population_specificity": "Not specified (general discussion of neurodegenerative disease mechanisms)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:25.995704+00:00"}
{"study_id": 105678, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the impact of silymarin (not Alanine) in patients with chronic hepatitis C who failed conventional antiviral therapy.", "results_summary": "The abstract does not report specific results regarding Alanine's effects, as the study focused on silymarin. Key aspects of botanical product trials were highlighted, including product standardization and outcome variable selection.", "population_specificity": "Chronic hepatitis C patients who were nonsustained virologic responders to IFN-based therapy.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:30.660817+00:00"}
{"study_id": 105680, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers compared clinical and laboratory findings between hepatitis A and scrub typhus patients, focusing on alanine aminotransferase (ALT) levels as a diagnostic marker.", "results_summary": "Elevated ALT levels (\u2265 500 U/L) were far more common in hepatitis A patients (87.5%) than in scrub typhus patients (1%). The ALT:lactate dehydrogenase ratio also effectively differentiated the two conditions.", "population_specificity": "104 hepatitis A patients and 197 scrub typhus patients.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:30.923986+00:00"}
{"study_id": 105682, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to determine the prevalence of insulin resistance (IR) and its associations with metabolic and clinical factors, including alanine aminotransferase levels, in HIV-infected children.", "results_summary": "The study found that IR was associated with higher alanine aminotransferase levels, among other factors, in HIV-infected children, but did not specifically assess alanine's direct effects or safety.", "population_specificity": "HIV-infected children from the Pediatric HIV/AIDS Cohort Study (n=451).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:31.716180+00:00"}
{"study_id": 105677, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to review the clinical effectiveness of insulin sensitisers, including metformin and pioglitazone, in treating NAFLD, with a focus on their impact on alanine aminotransferase levels.", "results_summary": "Both metformin and pioglitazone reduced alanine aminotransferase levels, though pioglitazone's reduction was comparable to that caused by vitamin E. Metformin showed greater improvements in glycemic control and weight reduction compared to pioglitazone.", "population_specificity": "Patients with non-alcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified", "study_duration": "Most trials lasted between 6 and 12 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:32.019249+00:00"}
{"study_id": 105679, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers were attempting to determine the efficacy and safety of alternative antifungal combination treatments for HIV-associated cryptococcal meningitis, including regimens involving fluconazole and voriconazole, compared to the standard amphotericin B plus flucytosine therapy.", "results_summary": "The study found no statistically significant differences in the rate of clearance of cryptococcal infection or mortality among the four treatment groups, including those involving fluconazole or voriconazole. No significant increases in alanine transaminase levels or other severe laboratory abnormalities were observed.", "population_specificity": "HIV-seropositive, antiretroviral-naive patients with cryptococcal meningitis.", "effective_dosage": "Not applicable (study focused on antifungal combinations, not alanine).", "study_duration": "2 weeks.", "interactions": "None mentioned (regarding alanine).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:32.148069+00:00"}
{"study_id": 105683, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the association between alanine aminotransferase (ALT) and insulin resistance (HOMA-IR) in postmenopausal women.", "results_summary": "The study found that alanine aminotransferase (ALT) was one of the important determinants of HOMA-IR in postmenopausal women, suggesting a link between ALT levels and insulin resistance. However, the abstract does not specify the direct effects of alanine supplementation.", "population_specificity": "Naturally postmenopausal women without overt diabetes (n=262).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:33.566234+00:00"}
{"study_id": 105681, "supplement_id": 863, "safety_score": "20", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to determine whether L-alanine supplementation influenced deoxysphingolipid (dSL) levels and disease severity in HSAN1, given its role as an alternative substrate for mutant SPT.", "results_summary": "A 10% L-alanine\u2013enriched diet increased dSL levels and led to severe peripheral neuropathy in mice with HSAN1, demonstrating its detrimental effects. The study suggests L-alanine exacerbates the disease by promoting neurotoxic dSL formation.", "population_specificity": "Mice with a transgene expressing the C133W SPTLC1 mutant linked to HSAN1; a pilot study with 14 HSAN1 patients (for L-serine, not L-alanine).", "effective_dosage": "10% L-alanine\u2013enriched diet (specific frequency not mentioned).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:33.954010+00:00"}
{"study_id": 105684, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate reinfection and superinfection during treatment for recent hepatitis C virus (HCV) and assess the role of alanine aminotransferase (ALT) levels as a clinical marker.", "results_summary": "The study found that reinfection and superinfection occurred during HCV treatment, with ALT levels >1.5\u00d7 the upper limit of normal observed in 71% of reinfection cases. These events were associated with poor social functioning and ongoing injecting drug use (IDU).", "population_specificity": "163 patients with recent HCV infection, including treated (n=111) and untreated (n=52) groups.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:35.078065+00:00"}
{"study_id": 105685, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine if salivary alanine aminotransferase (ALT) levels could predict the progression of periodontitis.", "results_summary": "The study found that ALT levels, when combined with the P. gingivalis ratio, showed high specificity (0.96) and likelihood (11.30) for predicting periodontitis progression.", "population_specificity": "85 chronic periodontitis patients.", "effective_dosage": "Not specified.", "study_duration": "18 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:39.727072+00:00"}
{"study_id": 105687, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of omega-3 PUFA supplementation on liver fat and liver function tests, including alanine aminotransferase (ALT), in individuals with NAFLD.", "results_summary": "Omega-3 PUFA supplementation showed significant benefits in reducing liver fat and AST levels, with a non-significant trend toward improving ALT levels. Sub-analyses of RCTs confirmed the liver fat reduction but not ALT or AST improvements.", "population_specificity": "Obese individuals with NAFLD (355 participants across 9 studies).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:40.189314+00:00"}
{"study_id": 105686, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the therapeutic response and hepatic functional reserve improvement in HCV-associated HCC patients receiving PEG-IFN a-2b/RBV therapy after curative treatment.", "results_summary": "The study found that PEG-IFN a-2b/RBV therapy improved cumulative survival rates (100% at 1 year, 90.2% at 3 years) and hepatic functional reserve in HCV-associated HCC patients compared to the non-treatment group. Univariate analysis identified secondary IFN treatment, alanine aminotransferase, and albumin levels as factors contributing to survival.", "population_specificity": "54 patients with initial HCV-associated Stage I/II HCC (29 treated with PEG-IFN a-2b/RBV, 25 untreated).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:40.627914+00:00"}
{"study_id": 105689, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of a probiotic mixture (Lactobacillus bulgaricus and Streptococcus thermophilus) on liver function markers, including alanine aminotransferase (ALT), in patients with non-alcoholic fatty liver disease (NAFLD).", "results_summary": "The probiotic treatment significantly reduced ALT, AST, and gammaGT levels in NAFLD patients, while placebo showed no significant changes. Anthropometric and cardiovascular risk factors remained unchanged in both groups.", "population_specificity": "28 patients with NAFLD diagnosed by liver biopsy.", "effective_dosage": "500 million Lactobacillus bulgaricus and Streptococcus thermophilus per day (one tablet).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:41.113866+00:00"}
{"study_id": 105688, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study aimed to compare the efficacy and safety of elvitegravir versus raltegravir in treatment-experienced HIV patients, not specifically to evaluate alanine.", "results_summary": "The study found that elvitegravir had similar efficacy and safety to raltegravir, with more patients on raltegravir experiencing grade 3 or 4 rises in alanine aminotransferase. Alanine itself was not the focus of the study.", "population_specificity": "Treatment-experienced HIV patients with resistance to or experience with at least two classes of antiretroviral drugs.", "effective_dosage": "Not applicable (study did not focus on alanine dosage).", "study_duration": "48 weeks.", "interactions": "None mentioned (for alanine specifically).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:41.558172+00:00"}
{"study_id": 105692, "supplement_id": 863, "safety_score": "60", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to summarize the scientific review of pazopanib's application for treating advanced renal cell carcinoma, including its safety and efficacy.", "results_summary": "Pazopanib increased progression-free survival to 9.2 months compared to 4.2 months with placebo, but common side effects included elevated alanine aminotransferase and other adverse events.", "population_specificity": "Patients with advanced renal cell carcinoma.", "effective_dosage": "800 mg once daily.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:42.354156+00:00"}
{"study_id": 105690, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to determine the incidence of hyperlactatemia and lactic acidosis in HIV-exposed infants and assess any associations with neurological or neurodevelopmental disorders, using alanine levels as part of the diagnostic criteria.", "results_summary": "The study found no significant association between ARV use and pathological hyperlactatemia or neurological disorders in HIV-exposed infants. Hyperlactatemia was common in both HIV-exposed and unexposed infants, with no link to adverse neurological outcomes.", "population_specificity": "Infants born to HIV-infected mothers and infants born to HCV-infected mothers during their first year of life.", "effective_dosage": "Not specified", "study_duration": "Follow-up at 1.5, 3, 6, and 12 months of life.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:44.023294+00:00"}
{"study_id": 105691, "supplement_id": 863, "safety_score": "65", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the safety and efficacy of teriflunomide, including its impact on alanine aminotransferase levels, in patients with relapsing forms of multiple sclerosis.", "results_summary": "Teriflunomide increased the incidence of elevated alanine aminotransferase levels (54.0% and 57.3% for 7 mg and 14 mg doses, respectively) compared to placebo (35.9%), but severe elevations (\u22653 times the upper limit) were similar across groups. No deaths occurred, and serious infections were rare.", "population_specificity": "Patients with relapsing multiple sclerosis, aged 18-55, with an Expanded Disability Status Scale score of 0-5.5 and recent relapse history.", "effective_dosage": "7 mg or 14 mg once daily.", "study_duration": "108 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:44.218918+00:00"}
{"study_id": 105693, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 50, "study_goal": "The researchers aimed to identify a novel mutation in the androgen receptor gene (AR) involving an alanine substitution and its association with mild androgen insensitivity syndrome (MAIS) and azoospermia.", "results_summary": "The study identified a novel mutation (A240S) in the AR gene, resulting in an alanine to serine substitution, linked to MAIS and azoospermia. Hormonal evaluation showed normal testosterone but elevated gonadotropins in the patient.", "population_specificity": "A 49-year-old man with undermasculinized features, cryptorchidism, and azoospermia.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:48.328235+00:00"}
{"study_id": 105694, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers investigated whether weight loss in excessively obese adults improves cardiometabolic risk factors, including alanine aminotransferase levels.", "results_summary": "Weight loss correlated with significant improvements in alanine aminotransferase levels, among other cardiometabolic markers. The greatest improvements were seen with \u2265 20% weight loss.", "population_specificity": "Excessively obese adults (BMI 40-60 kg/m\u00b2), including 48 with type 2 diabetes mellitus.", "effective_dosage": "Not specified", "study_duration": "Followed during 2005-2008 (exact intervention duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:48.329532+00:00"}
{"study_id": 105695, "supplement_id": 863, "safety_score": "30", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and safety of MK-0633, a 5-lipoxygenase inhibitor, in patients with chronic asthma, including its impact on alanine aminotransferase levels.", "results_summary": "MK-0633 100 mg showed significant improvement in FEV(1) and other secondary endpoints compared to placebo, but it was associated with dose-dependent increases in alanine aminotransferase, leading to termination of extended study periods due to an unfavorable benefit-risk ratio.", "population_specificity": "Patients aged 18-70 with chronic asthma and FEV(1) \u226545% and \u226485% predicted.", "effective_dosage": "10 mg, 50 mg, and 100 mg once daily.", "study_duration": "6-week primary period, with optional extensions up to 52 weeks (terminated early).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:50.125493+00:00"}
{"study_id": 105698, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the role of alanine aminotransferase (ALT) levels as a biomarker for identifying chronic hepatitis B (CHB) patients who are candidates for antiviral therapy.", "results_summary": "The study found that elevated ALT levels, along with HBV DNA levels >10\u2074 copies/mL, are key indicators for initiating antiviral therapy in CHB patients. It also highlighted specific conditions (e.g., serum albumin \u22643.5 g/dL, platelet count \u2264130,000 mm\u00b3) where treatment is recommended even with normal ALT levels.", "population_specificity": "Asian Americans with chronic hepatitis B (HBeAg-positive or -negative).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:51.138715+00:00"}
{"study_id": 105697, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study assessed the activity and safety of eribulin in patients with different types of soft-tissue sarcoma, not Alanine.", "results_summary": "The study found that eribulin showed varying progression-free survival rates at 12 weeks across different sarcoma types, with common adverse events including neutropenia and leucopenia. Abnormal alanine aminotransferase concentrations were noted in 5% of patients.", "population_specificity": "Patients with progressive or high-grade soft-tissue sarcoma (adipocytic sarcoma, leiomyosarcoma, synovial sarcoma, and other sarcomas).", "effective_dosage": "Eribulin was given intravenously at 1.4 mg/m\u00b2 on days 1 and 8 every 3 weeks.", "study_duration": "Treatment cycles were every 3 weeks; specific total duration not stated.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:51.561184+00:00"}
{"study_id": 105696, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare hepatic, gastrointestinal, and cardiac toxicity between PRECISION TACE with drug-eluting beads (DEB) and conventional TACE with doxorubicin in treating intermediate-stage hepatocellular carcinoma (HCC).", "results_summary": "The study found that PRECISION TACE with DEB resulted in significantly lower increases in alanine transaminase (50% less) and aspartate transaminase (41% less) compared to conventional TACE, with fewer liver toxicity events (16.1% vs. 25%). There was also a small but significant difference in cardiac function (LVEF change of 4 percentage points favoring DEB TACE).", "population_specificity": "212 patients (185 men, 27 women; mean age 67 years) with intermediate-stage HCC, predominantly in advanced stages (67% in both groups).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:52.510560+00:00"}
{"study_id": 105699, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to investigate the association between immune responses and liver enzyme elevation (specifically alanine transaminase) in HIV and hepatitis C co-infected patients during combination antiretroviral therapy.", "results_summary": "The study found that subjects with liver enzyme elevation had higher immune responses against hepatitis C virus and other viral antigens, as well as consistently higher anti-hepatitis C virus antibody levels, suggesting a link between immune reconstitution and liver transaminase elevation.", "population_specificity": "12 subjects with HIV and hepatitis C virus co-infection, five of whom had alanine transaminase elevation.", "effective_dosage": "Not specified", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:53.839327+00:00"}
{"study_id": 105700, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to assess the clinical and laboratory determinants of liver stiffness, measured by transient elastography, in rheumatoid arthritis patients treated with methotrexate, focusing on factors like alanine transaminase levels.", "results_summary": "The study found a significant correlation between liver stiffness and methotrexate cumulative dose, duration of treatment, and alanine transaminase levels, with mild or moderate fibrosis detected in some patients with high cumulative doses and liver stiffness >9 kPa.", "population_specificity": "100 patients with rheumatoid arthritis treated with methotrexate.", "effective_dosage": "Cumulative methotrexate dose ranging from 1530 to 13,000 mg.", "study_duration": "Mean period of 7.07\u00b13.89 years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:53.948429+00:00"}
{"study_id": 105701, "supplement_id": 863, "safety_score": "85", "efficacy_score": null, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the safety profile of caspofungin (CAS) in adult and paediatric patients across various clinical conditions.", "results_summary": "The study found that 41.8% of CAS recipients experienced drug-related adverse events, with the most common being fever, chills, and increased liver enzymes. Serious AEs were rare (0.8% attributed to CAS), and discontinuation due to AEs was infrequent (2.7%).", "population_specificity": "Adult and paediatric patients, including those with oropharyngeal/oesophageal candidiasis, invasive candidiasis, invasive aspergillosis, and persistent fever with neutropenia.", "effective_dosage": "Daily doses ranging from 5mg to 210mg.", "study_duration": "Up to 196 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:57.052594+00:00"}
{"study_id": 105702, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to compare the effects of caloric restriction alone or combined with exercise on liver enzymes (including alanine aminotransferase, ALT) in obese metabolic syndrome subjects and identify predictors of changes in these enzymes.", "results_summary": "ALT levels decreased by 20% with caloric restriction and 24% with caloric restriction plus exercise, indicating significant improvement. Reduction in abdominal fat mass and dietary saturated fat intake were key predictors of ALT improvement.", "population_specificity": "Sedentary men and women aged 55 \u00b1 6 years with obesity and metabolic syndrome.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:57.525656+00:00"}
{"study_id": 105703, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the adverse-event risks, including alanine aminotransferase (ALT) elevations, across different statins used for cardiovascular disease prevention.", "results_summary": "The study found that statins, as a class, significantly elevated ALT levels compared to controls (OR: 1.28; 95% CI: 1.11-1.48). Atorvastatin specifically showed higher AST elevations compared to pravastatin.", "population_specificity": "159,458 patients from 72 randomized clinical trials focused on cardiovascular disease prevention.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:58.282408+00:00"}
{"study_id": 105704, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to validate the APRI (aspartate aminotransferase-to-platelet ratio index) as a non-invasive marker for liver fibrosis in NAFLD patients, comparing it to NFS and AST/ALT ratio.", "results_summary": "APRI showed higher sensitivity (75%) and specificity (86%) for detecting advanced fibrosis compared to NFS, with a superior positive predictive value (54% vs. 34%). The study concluded APRI is a favorable alternative for fibrosis prediction in NAFLD.", "population_specificity": "111 patients with histological diagnoses of NAFLD, grouped into FLD, NASH, no/mild fibrosis, and advanced fibrosis.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:42:59.920982+00:00"}
{"study_id": 105706, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to compare the clinical outcomes, including liver injury markers (AST and ALT), between hemihepatic vascular occlusion (HHO) and total hepatic inflow occlusion (THO) in patients undergoing hepatectomy.", "results_summary": "The study found no significant difference in blood loss, transfusion requirement, mortality, morbidity, or other clinical outcomes between HHO and THO groups. However, THO was associated with higher AST levels on postoperative day 1, indicating greater liver injury compared to HHO.", "population_specificity": "Patients undergoing hepatic resection (338 participants across 4 RCTs).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:01.411949+00:00"}
{"study_id": 105708, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to analyze and compile laboratory abnormalities, including alanine aminotransferase levels, in patients with Myotonic Dystrophy Type 2 (DM2).", "results_summary": "The study found that alanine aminotransferase levels were abnormally elevated in more than 50% of DM2 patients, indicating potential liver involvement or dysfunction. No direct effects or benefits of alanine supplementation were assessed.", "population_specificity": "Eighty-three adults with genetically confirmed or clinically probable DM2, of which 49 had documented baseline laboratory screening.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:02.392977+00:00"}
{"study_id": 105705, "supplement_id": 863, "safety_score": "70", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of PEG-interferon \u03b1-2a and weight-based ribavirin doses in patients with chronic hepatitis C and persistently normal alanine transaminase levels.", "results_summary": "The study found an 85.4% sustained virological response (SVR) rate, with higher efficacy in patients with \"easy\" genotypes (92.2%) compared to \"difficult\" genotypes (74.3%). Female patients with easy genotypes had a 100% SVR rate.", "population_specificity": "Patients with chronic hepatitis C and persistently normal alanine transaminase levels (227 participants, 55 men and 172 women).", "effective_dosage": "PEG-interferon \u03b1-2a 180 mg/week and ribavirin (800 mg/day for weight <60 kg; 1000 mg/day for weight >60 and <75 kg; 1200 mg/day for weight >75 kg).", "study_duration": "24 weeks for genotype 2 or 3, 48 weeks for genotype 1 or 4.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:02.637752+00:00"}
{"study_id": 105707, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers compared the safety and efficacy of two different schedules (CG1 and CG8) of gemcitabine and carboplatin in treating advanced non-small cell lung cancer, not specifically focused on Alanine.", "results_summary": "The study found that CG1 had a higher response rate (29.2%) compared to CG8 (22.2%), but CG8 showed improved toxicities and a tendency toward prolonged survival. Grade \u22653 liver enzyme elevations (including alanine aminotransferase) were mainly observed in CG8.", "population_specificity": "Patients with advanced non-small cell lung cancer.", "effective_dosage": "Not specified for Alanine.", "study_duration": "3-weekly regimens.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:04.161922+00:00"}
{"study_id": 105709, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not focus on Alanine but rather evaluates micafungin's safety, efficacy, and dosing in children for invasive fungal infections.", "results_summary": "The study does not report findings on Alanine; it discusses micafungin's antifungal activity, dosing, and adverse effects, including elevation of alanine aminotransferase/aspartate aminotransferase values.", "population_specificity": "Immunocompromised children with invasive fungal infections or at risk for such infections.", "effective_dosage": "Not applicable (study focuses on micafungin).", "study_duration": "Not specified for Alanine.", "interactions": "None mentioned for Alanine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:05.206454+00:00"}
{"study_id": 105711, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the diagnostic performance of alanine aminotransferase (ALT) as a biomarker for chronic alcohol misuse compared to other indirect and direct biomarkers.", "results_summary": "ALT was found to be highly correlated with AST but exhibited low sensitivity and specificity in discriminating heavy drinkers from social and non-drinkers, suggesting limited diagnostic utility for chronic alcohol abuse.", "population_specificity": "175 subjects classified as non-drinkers (N=65), social drinkers (N=51), and active heavy drinkers (N=59).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:06.857160+00:00"}
{"study_id": 105710, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were attempting to evaluate the feasibility and safety of using \u00b9\u00b2\u2075I seed strands for intraluminal brachytherapy (ILBT) in treating malignant obstructive jaundice (MOJ) and its effect on stent patency, not Alanine.", "results_summary": "The study found that ILBT with \u00b9\u00b2\u2075I seed strands prolonged stent patency (10.2 months vs. 7.2 months in controls) without significant differences in serum bilirubin, alanine aminotransferase, granulocytes, or platelets between groups.", "population_specificity": "34 patients with malignant obstructive jaundice (MOJ).", "effective_dosage": "Not applicable (study focused on \u00b9\u00b2\u2075I seed strands, not Alanine).", "study_duration": "Follow-up at 2 and 4 weeks post-procedure; stent patency monitored over months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:07.152461+00:00"}
{"study_id": 105712, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effects of Bifidobacterium longum with fructo-oligosaccharides (Fos) combined with lifestyle modification on non-alcoholic steatohepatitis (NASH) compared to lifestyle modification alone.", "results_summary": "The study found that Bifidobacterium longum with Fos and lifestyle modification significantly reduced AST, LDL cholesterol, CRP, TNF-\u03b1, HOMA-IR, serum endotoxin, steatosis, and the NASH activity index compared to lifestyle modification alone.", "population_specificity": "66 patients with non-alcoholic steatohepatitis (NASH).", "effective_dosage": "Not specified in the abstract.", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:08.410000+00:00"}
{"study_id": 105714, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers investigated the clinical and histologic features of NAFLD, including alanine aminotransferase levels, in Korean young men.", "results_summary": "The study found that most Korean young men with NAFLD had borderline or definite NASH, with the overlap type showing higher NAS and fibrosis stages compared to other types. Alanine aminotransferase levels were significantly higher in the definite NASH group.", "population_specificity": "Korean young men under age 30 diagnosed with NAFLD by liver biopsy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:10.734884+00:00"}
{"study_id": 105713, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The study aimed to compare the clinical features, recurrence rates, and survival outcomes of early-stage cryptogenic cirrhosis-associated hepatocellular carcinoma (CC-HCC) versus HCV-associated HCC (HCV-HCC), with a focus on prognostic factors including alanine aminotransferase levels.", "results_summary": "CC-HCC patients had larger tumors but lower recurrence rates and higher survival rates compared to HCV-HCC patients. High alanine aminotransferase levels were a significant factor for recurrence in HCV-HCC but not in CC-HCC.", "population_specificity": "Patients with early-stage hepatocellular carcinoma (36 CC-HCC and 211 HCV-HCC) who received curative treatment.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:11.226112+00:00"}
{"study_id": 105716, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether alanine transaminase (ALT) levels could serve as a prognostic indicator for short-term survival (two weeks) in patients with advanced cancer.", "results_summary": "The study found that alanine transaminase (ALT) was one of four variables with prognostic significance for two-week survival in advanced cancer patients, though it did not predict longer-term survival. The composite models incorporating ALT performed comparably or better than clinicians' survival estimates.", "population_specificity": "1018 patients with locally advanced or metastatic cancer, no longer receiving cancer treatment, and recently referred to palliative care services in the UK.", "effective_dosage": "Not available", "study_duration": "Not applicable (observational study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:13.364582+00:00"}
{"study_id": 105715, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers were investigating the association between sustained virological response (SVR) and insulin resistance (IR) in patients with chronic hepatitis C virus (HCV) genotypes 1 and 2/3, not specifically studying Alanine.", "results_summary": "The study found that SVR was associated with a significant reduction in HOMA-IR (a measure of insulin resistance) in patients with HCV genotype 1 but not in those with genotype 2/3. This suggests genotype 1 may have a direct effect on IR, independent of metabolic factors.", "population_specificity": "Treatment-naive patients with chronic HCV genotype 1 or 2/3 (n=2255, with paired HOMA-IR data in 1038 non-diabetic patients).", "effective_dosage": "Not specified (study compared albinterferon alpha-2b vs. pegylated interferon alpha-2a, not Alanine).", "study_duration": "48 weeks for genotype 1, 24 weeks for genotype 2/3.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:14.416940+00:00"}
{"study_id": 105718, "supplement_id": 863, "safety_score": "70", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety and efficacy of BUP/NX, including its effects on alanine aminotransferase (ALT) levels, in opioid-dependent injectors in China and Thailand.", "results_summary": "BUP/NX was well tolerated and effective in reducing opioid withdrawal symptoms, but 17% of subjects experienced grade 2 or 3 ALT increases, which were associated with baseline ALT elevation.", "population_specificity": "Chinese and Thai opioid-dependent injectors.", "effective_dosage": "Not specified in the abstract.", "study_duration": "4-week follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:14.597887+00:00"}
{"study_id": 105717, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare the antiviral effect of Peg-IFN plus ribavirin therapy in chronic hepatitis C patients with normal alanine aminotransferase (ALT) levels versus those with elevated ALT levels.", "results_summary": "The study found that the sustained virological response (SVR) rates were equivalent between patients with normal and elevated ALT levels, though ALT elevation occurred post-treatment in approximately 40% of non-SVR patients with normal baseline ALT.", "population_specificity": "386 chronic hepatitis C patients (193 with normal ALT, 193 with elevated ALT), including those with HCV genotype 1 and 2.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:14.695792+00:00"}
{"study_id": 105720, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study aimed to evaluate the efficacy and safety of moxifloxacin, not Alanine, in treating community-acquired bacterial pneumonia.", "results_summary": "The study found significant improvements in clinical parameters and bacterial eradication with moxifloxacin treatment, but no results related to Alanine were reported.", "population_specificity": "18 patients with community-acquired bacterial pneumonia.", "effective_dosage": "400 mg once daily (moxifloxacin).", "study_duration": "Not specified (treatment continued until completion).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:15.938967+00:00"}
{"study_id": 105719, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers compared the safety, toxicity, and tumor response of conventional transarterial chemoembolization versus drug-eluting bead (DEB) transarterial chemoembolization in hepatocellular carcinoma (HCC), noting changes in alanine aminotransferase levels as a secondary outcome.", "results_summary": "The study found a significant increase in alanine aminotransferase levels 24 hours after treatment, which was greater after conventional chemoembolization than DEB chemoembolization. No other differences in liver toxicity were observed between the groups.", "population_specificity": "Patients with unresectable HCC unsuitable for ablative therapies (mean age 70 \u00b1 7.7 years).", "effective_dosage": "Not specified", "study_duration": "Mean follow-up was 816 days \u00b1 361.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:17.836574+00:00"}
{"study_id": 105722, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine the clinical significance of serum DHEAS in patients with NAFLD, including its relationship with serum alanine aminotransferase (ALT) levels.", "results_summary": "The study found that serum DHEAS levels were significantly higher in NAFLD patients, particularly those with elevated ALT levels. Serum ALT was positively correlated with serum DHEAS, triglycerides, and body mass index.", "population_specificity": "158 Japanese men without viral hepatic diseases or excessive alcohol intake.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:18.659025+00:00"}
{"study_id": 105721, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the effects of aerobic training (AT), resistance training (RT), and their combination (AT/RT) on liver enzymes, including alanine aminotransferase, and other metabolic markers in overweight and sedentary individuals.", "results_summary": "AT significantly reduced liver fat, visceral fat, alanine aminotransferase, and insulin resistance (HOMA), while RT only reduced subcutaneous abdominal fat. AT was more effective than RT for improving visceral fat and liver-related markers, and the combination (AT/RT) showed effects similar to AT alone.", "population_specificity": "Overweight, sedentary adults (18-70 years old) with moderate dyslipidemia.", "effective_dosage": "Not applicable (exercise interventions, not alanine supplementation).", "study_duration": "8 months (following a 4-month run-in period).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:20.589028+00:00"}
{"study_id": 105724, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 80, "study_goal": "The researchers sought to determine the effects of metformin on serum hepatic parameters, including alanine aminotransferase, in women with PCOS.", "results_summary": "The study found that metformin did not significantly change liver transaminase levels, including alanine aminotransferase, but the highest tertile of baseline levels showed the largest decrease regardless of treatment arm.", "population_specificity": "626 infertile women with PCOS and mildly abnormal liver function parameters.", "effective_dosage": "Not specified for alanine.", "study_duration": "Up to 6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:22.709314+00:00"}
{"study_id": 105723, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to assess the activity and safety of ipilimumab in patients with metastatic uveal melanoma, including monitoring for adverse events such as alanine/aspartate aminotransferase elevation.", "results_summary": "The study found no objective responses in UM patients treated with ipilimumab, though some had stable disease. One patient experienced grade 3 alanine/aspartate aminotransferase elevation, which resolved with steroid therapy.", "population_specificity": "Thirteen pretreated patients with metastatic uveal melanoma from six European institutions.", "effective_dosage": "Induction treatment with ipilimumab 10 mg/kg, followed by maintenance doses at physicians' discretion.", "study_duration": "Tumor assessments were conducted at baseline, Week 12, Week 24, and Week 36.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:22.775838+00:00"}
{"study_id": 105725, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to determine the maximum tolerated dose, pharmacokinetic/pharmacodynamic relationships, and clinical activity of pazopanib in patients with advanced hepatocellular carcinoma, not specifically Alanine.", "results_summary": "The study found dose-limiting toxicities at higher pazopanib doses, established 600 mg QD as the MTD, and observed reductions in tumor vessel leakage via DCE-MRI, but did not focus on Alanine's effects.", "population_specificity": "Asian patients with advanced hepatocellular carcinoma (Child-Pugh class A).", "effective_dosage": "Pazopanib doses ranged from 200-800 mg once daily.", "study_duration": "21-day cycles (specific total duration not stated).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:24.984951+00:00"}
{"study_id": 105726, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of long-term interferon-alpha treatment on telomere length in peripheral blood T lymphocytes and its correlation with alanine aminotransferase levels in Hepatitis-C virus-infected subjects.", "results_summary": "The study found an inverse correlation between alanine aminotransferase levels and na\u00efve CD8(+) T cell telomere loss in the control group but not in the interferon-alpha group. Telomere length at screening inversely correlated with Hepatitis-C viral load and body mass index.", "population_specificity": "29 Hepatitis-C virus-infected subjects who failed to achieve a sustained virologic response after initial treatment.", "effective_dosage": "Not specified for alanine.", "study_duration": "Additional 3.5 years after initial 24 weeks of treatment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:25.379905+00:00"}
{"study_id": 105727, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether add-on adefovir (ADV) was a superior rescue strategy compared to switching to entecavir (ETV) for treating chronic hepatitis B (CHB) patients with lamivudine (LAM) resistance.", "results_summary": "The study found that LAM plus ADV combination therapy was more effective and produced longer-lasting effects than switching to ETV monotherapy, with faster and greater HBV DNA reduction rates at 24 weeks post-therapy. However, there were no statistical differences in virologic response, ALT normalization, and HBeAg seroconversion between the groups at 48 weeks.", "population_specificity": "Chronic hepatitis B (CHB) patients with lamivudine (LAM) resistance.", "effective_dosage": "Not specified", "study_duration": "48 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:25.550055+00:00"}
{"study_id": 105728, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the intercorrelations between changes in biomarkers, including alanine aminotransferase, during a prolonged dietary intervention in obese participants with or without type 2 diabetes.", "results_summary": "The study found that in participants with type 2 diabetes, a decrease in fasting glucose was correlated with decreases in alanine aminotransferase, suggesting a potential link between glycemic control and liver enzyme levels.", "population_specificity": "Obese participants (BMI 31 kg/m\u00b2), including 46 with type 2 diabetes, average age 52 years.", "effective_dosage": "Not specified", "study_duration": "2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:26.260075+00:00"}
{"study_id": 105729, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to evaluate the long-term safety and tolerability of aripiprazole in pediatric subjects with autistic disorder, not specifically Alanine.", "results_summary": "The study found that aripiprazole was generally safe and well-tolerated, with common adverse events including weight increase and aggression. One patient discontinued due to moderately increased alanine transaminase and aspartate transaminase levels.", "population_specificity": "Pediatric subjects (6-17 years) with autistic disorder.", "effective_dosage": "2-15 mg/d (aripiprazole, not Alanine).", "study_duration": "52 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:26.853732+00:00"}
{"study_id": 105730, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the hepatic effects of rosiglitazone/metformin (Rosi/Met) therapy on ALT levels, hepatic insulin sensitivity, and waist circumference in relation to type 2 diabetes prevention.", "results_summary": "Rosi/Met therapy lowered ALT levels in the first year and maintained this effect throughout the trial, but had no effect on central obesity and only a transient improvement in hepatic insulin sensitivity. The placebo arm showed no such benefits.", "population_specificity": "Subjects with impaired glucose tolerance (n = 207 total, 103 in Rosi/Met arm, 104 in placebo arm).", "effective_dosage": "Rosiglitazone 4 mg / Metformin 1000 mg (Rosi/Met).", "study_duration": "Median of 3.9 years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:30.174791+00:00"}
{"study_id": 105731, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether ischaemic preconditioning (IPC) reduces liver damage, as measured by serum alanine aminotransferase (ALT) levels, in patients undergoing major liver resection with intermittent vascular inflow occlusion.", "results_summary": "IPC did not reduce ALT levels or liver damage compared to the control group, with no significant difference in postoperative liver biochemistry tests between the groups.", "population_specificity": "Patients undergoing major liver resection with intermittent vascular inflow occlusion.", "effective_dosage": "Not applicable (IPC involved 10 min inflow occlusion followed by 10 min reperfusion).", "study_duration": "Single intraoperative intervention.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:30.805653+00:00"}
{"study_id": 105732, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the predictability of progression to a high-risk situation in women with gestational hypertension or mild pre-eclampsia at term, including the role of laboratory parameters like alanine aminotransferase.", "results_summary": "The study found that alanine aminotransferase was included in the final predictive model for progression to a high-risk situation, but its specific effects or efficacy were not detailed. The model's overall predictive accuracy was moderate (AUC 0.71).", "population_specificity": "Women with singleton pregnancies, cephalic presentation, 36\u201341 weeks gestation, and gestational hypertension or mild pre-eclampsia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:31.031013+00:00"}
{"study_id": 105733, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The study aimed to compare the efficacy and tolerability of erlotinib versus standard chemotherapy in patients with advanced EGFR mutation-positive NSCLC, not specifically to evaluate alanine.", "results_summary": "The study found that erlotinib-treated patients had significantly longer progression-free survival compared to chemotherapy. Increased alanine aminotransferase concentrations were noted as a grade 3 or 4 toxic effect in 4% of erlotinib-treated patients.", "population_specificity": "Patients older than 18 years with histologically confirmed stage IIIB or IV NSCLC and a confirmed activating EGFR mutation (exon 19 deletion or exon 21 L858R point mutation).", "effective_dosage": "Not applicable (alanine was not a primary intervention).", "study_duration": "Erlotinib was administered until disease progression or unacceptable toxic effects; chemotherapy was up to four cycles.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:33.996617+00:00"}
{"study_id": 105735, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were evaluating the tolerability and clinical efficacy of oxaliplatin and pemetrexed as an induction chemotherapy regimen in locally advanced head and neck squamous cell carcinoma (HNSCC), not specifically studying Alanine.", "results_summary": "The study reported predominantly grade 1 or 2 alanine aminotransferase/aspartate aminotransferase elevation as a side effect, but Alanine itself was not the focus of the research.", "population_specificity": "Patients with locally advanced head and neck squamous cell carcinoma (HNSCC).", "effective_dosage": "Not applicable (Alanine was not a studied intervention).", "study_duration": "4 cycles of chemotherapy administered every 14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:34.068966+00:00"}
{"study_id": 105734, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy and tolerance of tenofovir disoproxil fumarate (TDF) + emtricitabine (FTC) in patients with chronic hepatitis B (CHB), including its impact on alanine transaminase (ALT) levels.", "results_summary": "The study found that TDF + FTC showed strong antiviral efficacy, with 76% of patients achieving undetectable HBV-DNA at 48 weeks and 94% at 96 weeks. ALT levels remained stable, and no significant kidney function deterioration or viral breakthrough occurred.", "population_specificity": "78 consecutive CHB patients from five European centers, classified into treatment intensification (69%) and treatment simplification (31%) groups.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Median treatment duration was 76 weeks (interquartile range 60-116).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:34.578671+00:00"}
{"study_id": 105736, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether albumin administration could be replaced by other volume replacement products (HES or LR) in hepatocellular carcinoma patients undergoing hepatectomy, focusing on hemodynamic stability, liver function, and inflammatory response.", "results_summary": "The study found that HA, HES, and LR achieved similar hemodynamic stability and liver function outcomes, with HES requiring less volume and showing a more favorable effect on the acute phase response (lower CRP).", "population_specificity": "Hepatocellular carcinoma patients undergoing hepatectomy.", "effective_dosage": "20% human albumin (HA), 6% hydroxyethyl starch (HES), or lactated Ringer's solution (LR) for postoperative volume replacement.", "study_duration": "Postoperative days one, three, and five.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:35.059893+00:00"}
{"study_id": 105737, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the effectiveness of interferon-\u03b1 2b plus ribavirin treatment in chronic hepatitis C patients, with a focus on serum alanine transaminase (ALT) levels as a marker.", "results_summary": "The study found that 63.5% of patients responded to the treatment, with better outcomes observed in younger patients (\u226440 years) and those with lower viral loads (<8\u00d710^5 IU/ml). Serum ALT levels were quantified pre- and post-treatment, but specific effects of alanine were not detailed.", "population_specificity": "750 HCV-positive patients with genotype 3 (616 completed treatment) in Pakistan, categorized by gender, age, and viral load.", "effective_dosage": "Interferon-\u03b1 2b (3 million units thrice weekly) plus ribavirin (1000-1200 mg daily).", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:36.897672+00:00"}
{"study_id": 105740, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers were investigating the clinical presentation and complications of Brucella suis infection in humans, particularly noting elevated alanine aminotransferase levels.", "results_summary": "The study found that Brucella suis infection led to significantly increased median alanine aminotransferase levels (20 times greater than normal), but without associated hepatic pathology. The clinical presentation and complications were similar to other Brucella species infections.", "population_specificity": "Patients in Wallis and Futuna Islands with Brucella suis infection (21 cases).", "effective_dosage": "Not available", "study_duration": "Not applicable (observational study from 2003-2010)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:39.860928+00:00"}
{"study_id": 105739, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the association between antineoplastic treatment for childhood cancer and hepatic late adverse effects, particularly focusing on alanine aminotransferase (ALT) levels.", "results_summary": "The prevalence of hepatic late adverse effects, defined as elevated ALT levels, ranged from 7.9% to 52.8% in selected studies. Chronic viral hepatitis was identified as a potential risk factor, but specific antineoplastic treatments linked to hepatic late adverse effects remain unclear.", "population_specificity": "Childhood cancer survivors (aged 18 years or less at diagnosis) with follow-up durations varying from one to 27 years after treatment.", "effective_dosage": "Not specified", "study_duration": "Follow-up ranged from one to 27 years after treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:40.851736+00:00"}
{"study_id": 105742, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effectiveness and mechanism of ulinastatin (not Alanine) on liver function and clinical outcomes following hepatectomy.", "results_summary": "Ulinastatin significantly reduced serum alanine transaminase, aspartate transferase, inducible nitric oxide synthase, and tumor necrosis factor-\u03b1 levels, delayed bilirubin response, and improved clinical outcomes, particularly after major hepatectomy. It also reduced hospital length of stay and recovery-related costs.", "population_specificity": "176 patients undergoing hepatectomy (86 in treatment group, 90 in control group).", "effective_dosage": "Ulinastatin 150,000 U twice daily.", "study_duration": "3 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:42.361535+00:00"}
{"study_id": 105741, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to investigate the efficacy and safety of gefitinib as a first-line treatment for elderly patients with advanced lung adenocarcinoma and EGFR mutations, not specifically focused on Alanine.", "results_summary": "The study found that gefitinib was effective (59% response rate) and well-tolerated in elderly patients with EGFR mutations, with major toxicities including skin rash and elevated liver enzymes (aspartate aminotransferase or alanine aminotransferase).", "population_specificity": "Elderly patients (aged 75 or older) with advanced lung adenocarcinoma and EGFR mutations.", "effective_dosage": "250 mg once daily.", "study_duration": "Until disease progression or unacceptable toxicity.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:42.371878+00:00"}
{"study_id": 105744, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to identify clinical predictors of severe pandemic H1N1 pneumonia and their correlation with radiological findings, including serum alanine aminotransferase (ALT) levels.", "results_summary": "Higher serum ALT levels were associated with severe H1N1 pneumonia and positively correlated with radiological findings and the number of involved lung lobes.", "population_specificity": "Adults with pandemic H1N1 pneumonia (37 patients, 12 severe and 25 non-severe).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:42.420904+00:00"}
{"study_id": 105743, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the antidiabetic activity of purslane seeds (Portulaca oleracea) in type-2 diabetic subjects, comparing its effects to metformin.", "results_summary": "PO seeds significantly reduced triglycerides, cholesterol, LDL, liver enzymes (ALT, AST, GGT), bilirubin, blood glucose, insulin, body weight, and BMI, while increasing HDL and albumin. The effects were comparable to metformin, except for HDL, LDL, and ALP patterns.", "population_specificity": "Thirty subjects with type-2 diabetes.", "effective_dosage": "5 g of PO seeds twice daily.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:42.897561+00:00"}
{"study_id": 105745, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to compare outcomes in HIV/HBV-coinfected participants using HBV-active versus non-HBV-active ART, including effects on alanine aminotransferase levels.", "results_summary": "HIV/HBV-coinfected participants had higher baseline alanine aminotransferase levels compared to monoinfected participants. Lamivudine-containing ART showed limited HBV DNA suppression (33%) and did not significantly reduce mortality in coinfected individuals.", "population_specificity": "HIV/HBV-coinfected adults in the PHIDISA II study.", "effective_dosage": "Not specified for alanine.", "study_duration": "Follow-up included outcomes at week 48.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:45.674621+00:00"}
{"study_id": 105746, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were evaluating the safety and efficacy of autologous DC-tumor vaccine therapy in patients with malignant glioma, noting transient elevations in AST/ALT levels (including alanine aminotransferase).", "results_summary": "The study found that 47.1% of patients experienced transient elevation in AST/ALT levels, but the DC-tumor vaccine therapy showed some tumor shrinkage, increased CD8(+) lymphocytes, and prolonged survival compared to historical controls.", "population_specificity": "Patients with malignant glioma (16 with WHO grade IV, 1 with grade III).", "effective_dosage": "Each injection contained 1-6\u00d710^7 dendritic cells, administered 10 times over 6 months.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:48.445938+00:00"}
{"study_id": 105747, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The study aimed to assess the safety and efficacy of switching from enfuvirtide to raltegravir in patients with multidrug-resistant HIV infection, not specifically focused on Alanine.", "results_summary": "The study found that 18.2% of patients on raltegravir and ritonavir-boosted tipranavir experienced alanine aminotransferase elevations, leading to regimen adjustments in some cases. The abstract does not focus on Alanine's effects but mentions it as part of adverse event reporting.", "population_specificity": "Patients with multidrug-resistant HIV infection and suppressed plasma HIV RNA levels.", "effective_dosage": "Not specified for Alanine.", "study_duration": "48 weeks.", "interactions": "None mentioned for Alanine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:49.281500+00:00"}
{"study_id": 105738, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to examine the effect of HIV/AIDS on the pharmacokinetics of efavirenz, including the role of biochemical variables like alanine aminotransferase, in Ugandan patients.", "results_summary": "The study found that HIV/AIDS disease and sex significantly affect efavirenz pharmacokinetics, with HIV/AIDS patients showing reduced relative bioavailability and females having a higher volume of distribution and longer elimination half-life. Alanine aminotransferase was included as a covariate but its specific impact was not highlighted in the results.", "population_specificity": "Treatment-na\u00efve HIV-infected Ugandan patients and adult healthy subjects.", "effective_dosage": "600 mg efavirenz (single oral dose).", "study_duration": "Blood samples collected up to 24 hours post-dose.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:50.283565+00:00"}
{"study_id": 105749, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of thiazolidinediones on histological and biochemical variables, including alanine transaminase, in patients with non-alcoholic steatohepatitis (NASH).", "results_summary": "Thiazolidinediones modestly improved histological variables such as fibrosis, steatosis, inflammation, and hepatocellular ballooning but were associated with significant weight gain. The effect on alanine transaminase was noted as a secondary outcome, but specific results for alanine were not detailed in the abstract.", "population_specificity": "Patients with non-alcoholic steatohepatitis (NASH).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:51.324864+00:00"}
{"study_id": 105750, "supplement_id": 863, "safety_score": "70", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the longer-term effects and dose response of bardoxolone methyl on estimated GFR in patients with CKD and type 2 diabetes.", "results_summary": "Bardoxolone methyl significantly increased estimated GFR at 24 and 52 weeks compared to placebo, with dose-related effects. Adverse events included muscle spasms, hypomagnesemia, mild increases in alanine aminotransferase levels, and gastrointestinal effects.", "population_specificity": "Adults with CKD (estimated GFR 20-45 ml/min/1.73 m\u00b2) and type 2 diabetes.", "effective_dosage": "Target doses of 25, 75, or 150 mg once daily.", "study_duration": "52 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:51.510532+00:00"}
{"study_id": 105748, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the efficacy and safety of pegIFN\u03b1-2a combined with ribavirin in treating hepatitis C virus in Egyptian children and adolescents, including monitoring serum alanine aminotransferase (ALT) levels.", "results_summary": "The study found that 53.33% of patients achieved early virologic response (EVR), with serum ALT levels normalizing by week 12. Adverse effects included fever, myalgia, and hematologic changes, but no serious infections occurred.", "population_specificity": "Egyptian children and adolescents diagnosed with hepatitis C virus.", "effective_dosage": "pegIFN\u03b1-2a once weekly with ribavirin twice daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:52.351528+00:00"}
{"study_id": 105751, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the long-term morbidity and mortality of patients with NAFLD and advanced fibrosis or cirrhosis to those with HCV infection, including the role of alanine aminotransferase (ALT) levels in predicting outcomes.", "results_summary": "Lowered ALT levels in the NAFLD cohort were associated with liver-related complications, but the study did not focus on alanine as a supplement or its direct effects. The primary findings compared NAFLD and HCV outcomes, not alanine's efficacy or safety.", "population_specificity": "Patients with NAFLD or HCV infection and advanced fibrosis or cirrhosis (Child-Pugh class A).", "effective_dosage": "Not available", "study_duration": "Mean follow-up of 85.6 months for NAFLD cohort, 74.9 months for HCV cohort.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:53.923554+00:00"}
{"study_id": 105752, "supplement_id": 863, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine the efficacy of intravenous glycyrrhizin (SNMC) in reducing alanine aminotransferase (ALT) levels in patients with acute onset autoimmune hepatitis (AIH).", "results_summary": "The study found that early administration of SNMC effectively controlled ALT levels, with no significant difference compared to combined SNMC and corticosteroid therapy. Recovery rates were higher in the SNMC-only group, suggesting it may prevent disease progression in acute onset AIH.", "population_specificity": "31 patients with acute onset autoimmune hepatitis (AIH).", "effective_dosage": "100 ml/day of intravenous glycyrrhizin (SNMC).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:54.043784+00:00"}
{"study_id": 105753, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether intraportal tacrolimus perfusion during liver transplantation could reduce ischaemic reperfusion injury, as assessed by AST and ALT levels.", "results_summary": "Tacrolimus treatment did not reduce AST or ALT levels within the first week post-transplantation but suppressed inflammation and immune response on a genome-wide basis. No differences were observed in cholestatic parameters or liver synthesis between groups.", "population_specificity": "26 liver transplant recipients", "effective_dosage": "20 ng/ml tacrolimus in 1.5 l 5% albumin infusion", "study_duration": "Single administration during liver transplantation", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:57.357127+00:00"}
{"study_id": 105755, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine whether Arsenicum Album LM 0/3 could ameliorate arsenic toxicity symptoms in individuals exposed to contaminated drinking water.", "results_summary": "The study found that the homeopathic remedy slightly improved certain toxicity biomarkers, such as lowering matrix metalloproteinase activity, compared to placebo, but results were limited due to a high dropout rate.", "population_specificity": "Volunteers from an arsenic-contaminated village in West Bengal, India, with elevated arsenic levels in blood and urine.", "effective_dosage": "Not specified", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:57.474918+00:00"}
{"study_id": 105754, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of enteral nutrition (EN) and total parenteral nutrition (TPN) on biochemical and clinical outcomes, including alanine aminotransferase (ALT) levels, in pancreatic cancer patients post-pancreaticoduodenectomy.", "results_summary": "The study found significant differences in ALT levels and other biochemical markers between EN and TPN groups by the 7th and 14th postoperative days, with EN showing better outcomes. EN also had lower incidences of complications like delayed gastric emptying, pancreatic fistulas, and hemorrhages compared to TPN.", "population_specificity": "60 pancreatic cancer patients who underwent pancreaticoduodenectomy.", "effective_dosage": "Not specified", "study_duration": "Postoperative monitoring up to 14 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:43:58.069007+00:00"}
{"study_id": 105757, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to determine whether ischemic preconditioning (IP) combined with intermittent inflow occlusion improves outcomes in liver resections, focusing on markers like alanine aminotransferase (ALT) and local metabolic changes.", "results_summary": "IP did not reduce serum markers of ischemia-reperfusion injury (IRI) but improved local aerobic glucose metabolism (lower lactate, pyruvate, and glucose levels) in patients undergoing major liver resections. No differences were observed in ALT, AST, bilirubin, or PT-INR levels between groups.", "population_specificity": "Patients (n=32) with suspected malignant liver disease undergoing liver resections (minimum 2 segments), stratified by resection volume and without chronic liver disease.", "effective_dosage": "Not applicable (surgical intervention, not alanine supplementation).", "study_duration": "Patients were followed for 5 days postoperatively.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:01.175726+00:00"}
{"study_id": 105756, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of combined pioglitazone and exenatide therapy versus pioglitazone alone on hepatic fat content and plasma adiponectin levels in patients with type 2 diabetes.", "results_summary": "Combined therapy significantly increased plasma adiponectin levels and reduced hepatic fat content more than pioglitazone alone, while also showing a greater decrease in alanine aminotransferase (ALT) levels. Both treatments improved metabolic markers, but the combination was more effective without significant weight gain.", "population_specificity": "Patients with type 2 diabetes (age = 52 \u00b1 3 years, BMI = 32.0 \u00b1 1.5, HbA1c = 8.2 \u00b1 0.4%) on diet and/or metformin.", "effective_dosage": "Pioglitazone 45 mg/day; exenatide 10 \u00b5g subcutaneously twice daily.", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:01.313326+00:00"}
{"study_id": 105758, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the relationships among hepatic steatosis, HCV RNA levels, relapse, and rapid virologic response (RVR) in patients with HCV genotype 2 or 3 treated with interferon-\u03b1, focusing on predictors like alanine aminotransferase levels.", "results_summary": "The study found that steatosis and high baseline HCV RNA levels were strong independent predictors of relapse in HCV genotype 3 patients with an RVR. Alanine aminotransferase levels were included in the multivariate analysis but were not highlighted as a primary predictor of outcomes.", "population_specificity": "Patients with chronic hepatitis C virus (HCV) genotype 2 (n = 427) or 3 (n = 505) infections.", "effective_dosage": "Not specified", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:01.412589+00:00"}
{"study_id": 105759, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to evaluate the safety, pharmacokinetics, pharmacodynamics, and efficacy of brivanib combined with cetuximab in patients with advanced gastrointestinal malignancies, not specifically Alanine.", "results_summary": "The study reported manageable toxicities and an overall response rate of 10% with brivanib plus cetuximab, but did not specifically assess Alanine's effects.", "population_specificity": "Patients with advanced gastrointestinal malignancies who had failed prior therapies.", "effective_dosage": "Not applicable (study focused on brivanib and cetuximab, not Alanine).", "study_duration": "Not specified for Alanine.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:02.241245+00:00"}
{"study_id": 105760, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of alanine (control) and arginine on microcirculation in free transverse rectus abdominis myocutaneous flaps during breast reconstruction.", "results_summary": "Alanine was used as a control and showed lower microcirculatory blood flow in Zone IV postoperatively compared to arginine (p = 0.04), indicating it was less effective in improving microcirculation.", "population_specificity": "20 patients undergoing unilateral breast reconstruction with free transverse rectus abdominis myocutaneous flaps.", "effective_dosage": "Continuous intravenous infusion (specific dosage not mentioned).", "study_duration": "5 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:02.475784+00:00"}
{"study_id": 105762, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The study aimed to evaluate baseline abdominal ultrasound findings in infants with sickle cell anemia and examine relationships among ultrasound results, clinical data, and laboratory findings, including serum alanine aminotransferase levels.", "results_summary": "The study found no correlation between biliary sonographic findings and laboratory results, including alanine aminotransferase levels. Increased renal volume correlated with elevated glomerular filtration rates, but spleen volume did not reflect function.", "population_specificity": "Infants (7.5-18 months) with sickle cell anemia (116 girls and 87 boys).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:05.138257+00:00"}
{"study_id": 105761, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to compare postoperative early jaundice and transient liver damage in CABG patients receiving autologous or homologous blood transfusion, with a focus on liver enzyme levels including alanine transferase (ALT).", "results_summary": "The study found no significant changes in ALT levels between the ANH and control groups, suggesting no impact of transfusion type on ALT. However, bilirubin levels were significantly lower in the autologous transfusion group.", "population_specificity": "40 patients scheduled for coronary artery bypass grafting (CABG) surgery.", "effective_dosage": "Not available", "study_duration": "Measurements were taken within the first 24 hours post-surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:06.027639+00:00"}
{"study_id": 105763, "supplement_id": 863, "safety_score": "75", "efficacy_score": 60, "quality_score": 80, "study_goal": "The researchers aimed to determine the pharmacokinetics of vandetanib in Chinese patients with advanced solid tumors and compare these with data from Japanese and Western populations.", "results_summary": "The study found that vandetanib had low plasma clearance, a long half-life, and dose-dependent accumulation. Adverse events included rash and diarrhea, with one case of elevated alanine aminotransferase reported.", "population_specificity": "Chinese patients with advanced, solid, malignant tumors (age range 21-82 years, 56% male).", "effective_dosage": "100 mg every other day, 100 mg once daily, or 300 mg once daily.", "study_duration": "Until disease progression or discontinuation in the study (minimum 28 days per cohort).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:07.023075+00:00"}
{"study_id": 105766, "supplement_id": 863, "safety_score": "75", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy, safety, and tolerability of tofacitinib (CP-690,550) in Japanese patients with active rheumatoid arthritis (RA) who had an inadequate response to methotrexate (MTX).", "results_summary": "Tofacitinib demonstrated significant efficacy in improving ACR20 response rates, with dose-dependent effects, and showed a manageable safety profile with mild to moderate adverse events, including increased alanine aminotransferase levels.", "population_specificity": "Japanese patients with active rheumatoid arthritis receiving stable background methotrexate.", "effective_dosage": "1, 3, 5, and 10 mg twice a day.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:09.924066+00:00"}
{"study_id": 105768, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to identify factors influencing basal insulin requirement in insulin-na\u00efve patients with type 2 diabetes, including the role of alanine aminotransferase (ALT).", "results_summary": "The study found that alanine aminotransferase (ALT) was positively correlated with basal insulin requirement (\u03b3=0.310, P=0.027) and identified ALT as an independent predictor of basal insulin requirement. However, the abstract does not detail specific effects of alanine itself.", "population_specificity": "50 insulin-na\u00efve patients with type 2 diabetes.", "effective_dosage": "Not specified for alanine.", "study_duration": "Not specified for alanine.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:10.814259+00:00"}
{"study_id": 105767, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to determine the prevalence of HBV and HCV infections in an Italian cohort with type 2 diabetes mellitus (T2DM) and assess the relationship between metabolic syndrome and liver enzyme levels, including alanine aminotransferase (ALT).", "results_summary": "The study found a non-negligible prevalence of HBV and HCV infections in T2DM patients, with higher liver enzyme levels in virus-positive cases. A positive correlation between BMI and ALT levels was observed only in virus-negative patients.", "population_specificity": "859 consecutive patients with type 2 diabetes mellitus (413 females) from three Italian centers (Turin, Bologna, and Naples).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:11.047984+00:00"}
{"study_id": 105764, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to evaluate the efficacy and safety of a combination therapy with gemcitabine and irinotecan as first-line chemotherapy in patients with advanced biliary tract cancer (BTC), not specifically focused on Alanine.", "results_summary": "The study found that the combination therapy had an objective response rate of 20.5% and a disease control rate of 66.7%, with median progression-free survival of 4.3 months and overall survival of 7.6 months. Grade 3 and 4 toxicities included alanine transaminase increase (5.1%) among other adverse effects.", "population_specificity": "Patients with pathologically confirmed advanced biliary tract cancer (intrahepatic bile duct cancer, extrahepatic bile duct cancer, and gallbladder cancer).", "effective_dosage": "Not applicable (study did not focus on Alanine supplementation).", "study_duration": "Median of 4 cycles per patient (range 1-18), with each cycle lasting 3 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:11.406617+00:00"}
{"study_id": 105765, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to characterize the population pharmacokinetics of PM00104 (Zalypsis(\u00ae)) in cancer patients, including the effect of patient covariates on its pharmacokinetics.", "results_summary": "The study found that PM00104 exhibits linear elimination from plasma, dose proportionality up to 5,000 \u03bcg/m\u00b2, and time-independent pharmacokinetics. No clinically relevant covariates were identified as predictors of its pharmacokinetics.", "population_specificity": "Cancer patients (135 participants across four phase I clinical trials).", "effective_dosage": "Doses ranged from 53 to 5,000 \u03bcg/m\u00b2, administered as 1-, 3-, or 24-hour infusions every 3 weeks, or as 1-hour infusions on days 1, 8, and 15 of a 28-day cycle, or 1-hour infusions daily for 5 consecutive days every 3 weeks.", "study_duration": "Varied by dosing regimen (e.g., every 3 weeks, 28-day cycles, or 5 consecutive days every 3 weeks).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:12.600236+00:00"}
{"study_id": 105769, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the association between serum alanine aminotransferase (ALT) levels and the presence/severity of premature coronary artery disease (CAD).", "results_summary": "The study found that both ALT and AST levels were significantly correlated with the presence and angiographic severity of premature CAD, even after adjusting for confounders, suggesting these enzymes could serve as surrogate markers for cardiovascular risk.", "population_specificity": "187 younger patients (females < 55 years, males < 45 years) undergoing coronary angiography.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:13.140711+00:00"}
{"study_id": 105771, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers sought to determine the utility of the (13)C-caffeine breath test (CBT) in detecting hepatic fibrosis in NAFLD, including its correlation with alanine aminotransferase (ALT) levels.", "results_summary": "The study found that CBT significantly correlated with fibrosis severity in NAFLD but not with steatosis or inflammation. It also correlated with ALT levels (as part of the AST/ALT ratio), indicating potential utility in assessing liver function.", "population_specificity": "48 patients with NAFLD and 24 healthy controls.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:15.407014+00:00"}
{"study_id": 105770, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if intrahepatic markers, including alanine aminotransferase levels, could predict treatment response in chronic HBV patients treated with peg-interferon and adefovir.", "results_summary": "Baseline intrahepatic markers did not predict sustained virological response (SVR), but end-of-treatment reductions in intrahepatic cccDNA, total HBV DNA, and HBsAg/HBcAg-positive hepatocytes were associated with SVR in HBeAg-positive and negative patients.", "population_specificity": "Chronic HBV patients (16 HBeAg-positive, 24 HBeAg-negative).", "effective_dosage": "Not specified for alanine aminotransferase (monitored as a biomarker).", "study_duration": "48 weeks of treatment, with follow-up to week 72.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:15.593864+00:00"}
{"study_id": 105773, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the accuracy of alanine dosimeters in measuring radiation doses for IMRT (intensity-modulated radiation therapy) plans in a UK-wide dosimetric audit.", "results_summary": "The study found that 5.1% of alanine measurements differed by >5% from predicted doses, with three significant outliers. Excluding these, the mean difference was minimal (0.05%), indicating generally accurate dosimetry.", "population_specificity": "UK radiotherapy departments (57 centers participating).", "effective_dosage": "Not specified (measurements made per IMRT field).", "study_duration": "Audit conducted between June 2009 and March 2010.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:19.773455+00:00"}
{"study_id": 105774, "supplement_id": 863, "safety_score": "30", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers were investigating the occurrence of ketamine-induced liver injury, including elevated alanine transaminase levels, during repeated administrations of S(+)-ketamine for chronic pain treatment.", "results_summary": "Three out of six patients developed hepatotoxicity, marked by elevated liver enzymes (including alanine transaminase), with symptoms resolving after discontinuation of ketamine. The study suggests a risk of liver injury with prolonged or repeated ketamine infusions.", "population_specificity": "Patients with complex regional pain syndrome type 1 (n=6).", "effective_dosage": "Continuous intravenous S(+)-ketamine infusions (10-20 mg/h) for 100 hours, repeated after 16 days.", "study_duration": "Two 100-hour infusions separated by 16 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:20.142097+00:00"}
{"study_id": 105772, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the impact of low (20 mg/kg/d) and high (40 mg/kg/d) doses of deferasirox on echocardiographic indices in transfusion-dependent \u03b2-thalassemia major patients.", "results_summary": "Higher-dose deferasirox (40 mg/kg/d) improved tissue Doppler echocardiographic indices (lower E/Em ratio, higher systolic and diastolic wave velocities) compared to the lower dose (20 mg/kg/d), with no significant changes in left ventricle ejection fraction. Serum ferritin levels were significantly lower in the high-dose group.", "population_specificity": "Transfusion-dependent \u03b2-thalassemia major patients (n=38) and an age-matched control group (n=38).", "effective_dosage": "20 mg/kg/d and 40 mg/kg/d (deferasirox).", "study_duration": "6 months per dose group (total 12 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:20.262242+00:00"}
{"study_id": 105775, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were attempting to determine the effects and toxicities of a chemotherapy regimen (INP) involving irinotecan and nedaplatin in patients with extensive-stage small cell lung cancer, not specifically focused on Alanine.", "results_summary": "The study reported elevation of alanine aminotransferase as one of the toxicities but did not focus on Alanine's effects. The main outcomes were related to the chemotherapy regimen's efficacy and safety in SCLC patients.", "population_specificity": "Patients with histologically or cytologically confirmed extensive-stage small cell lung cancer (60 participants).", "effective_dosage": "Not applicable (study did not focus on Alanine supplementation).", "study_duration": "Treatment continued until tumor progression or unacceptable toxicity (median follow-up not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:20.860973+00:00"}
{"study_id": 105776, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were attempting to determine the safety and efficacy of everolimus in patients with advanced hepatocellular carcinoma (HCC), not Alanine.", "results_summary": "The study found that everolimus was well tolerated at 10 mg/day, with some grade 3-4 adverse events. Preliminary antitumor activity was observed, but the study did not proceed to the second stage of phase 2.", "population_specificity": "Patients with histologically confirmed measurable advanced HCC, 0-2 prior regimens, and adequate hematologic, hepatic, and renal functions.", "effective_dosage": "5 mg/day or 10 mg/day orally.", "study_duration": "6 weeks per cycle.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:20.978716+00:00"}
{"study_id": 105777, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not focus on determining the effects of Alanine but rather describes the characteristics and treatment of autoimmune hepatitis (AIH), where alanine aminotransferase levels are mentioned as a biochemical marker.", "results_summary": "The abstract does not report specific findings about Alanine's effects; it mentions elevated alanine aminotransferase levels as a biochemical feature of AIH.", "population_specificity": "Patients with autoimmune hepatitis (AIH), including adults and children.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:20.979416+00:00"}
{"study_id": 105779, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness and limitations of antiviral therapy, including its impact on alanine aminotransferase levels, in treating chronic hepatitis B virus infection.", "results_summary": "The study found that antiviral therapy effectively suppresses hepatitis B virus replication, normalizes alanine aminotransferase levels, and improves serological and histological markers, but it does not cure the disease and has limitations in resource-constrained settings.", "population_specificity": "Chronic hepatitis B virus-infected patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:23.515745+00:00"}
{"study_id": 105778, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine whether Sho-sai-ko-to (SST or Xiao Chai Hu Tang), which contains Alanine, could improve liver pathology in hepatitis C patients ineligible for interferon-based therapy.", "results_summary": "SST improved ALT levels in 75% of patients and AST levels in 67%, with mixed viral load responses. Histological improvement was observed in 38% of patients, with 21% meeting the predefined \"response\" criteria.", "population_specificity": "Chronic hepatitis C patients ineligible for interferon-based therapy (n=24).", "effective_dosage": "2.5 g orally three times daily.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:24.246555+00:00"}
{"study_id": 105781, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the metabolic and blood pressure effects of dietary supplementation with Agaricus sylvaticus, including its impact on alanine aminotransferase levels, in patients with colorectal cancer.", "results_summary": "The Agaricus sylvaticus group showed a significant reduction in alanine aminotransferase levels (p = 0.04), along with improvements in other metabolic and blood pressure parameters, compared to the placebo group.", "population_specificity": "56 patients with colorectal cancer in a postsurgical phase.", "effective_dosage": "30 mg/kg/day of Agaricus sylvaticus.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:28.637100+00:00"}
{"study_id": 105780, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether vitamin E or metformin could improve alanine aminotransferase (ALT) levels and histological features in children with NAFLD.", "results_summary": "Neither vitamin E nor metformin was superior to placebo in achieving sustained ALT reduction, though vitamin E showed some improvement in hepatocellular ballooning and NAFLD activity scores. Resolution of NASH was higher with vitamin E (58%) compared to placebo (28%) but not statistically significant for metformin (41%).", "population_specificity": "Children aged 8-17 years with biopsy-confirmed NAFLD.", "effective_dosage": "800 IU vitamin E daily, 1000 mg metformin daily.", "study_duration": "96 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:28.939377+00:00"}
{"study_id": 105782, "supplement_id": 863, "safety_score": "30", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and safety of lapaquistat acetate, a squalene synthase inhibitor, in lowering LDL cholesterol and other cardiovascular risk markers, with a focus on potential hepatic safety issues related to alanine aminotransferase elevations.", "results_summary": "Lapaquistat acetate significantly reduced LDL cholesterol by 21.6% in monotherapy and 18.0% in combination with statins, but it was associated with increased alanine aminotransferase levels and rare bilirubin elevations, leading to development termination due to hepatic safety concerns.", "population_specificity": "Dyslipidemic patients, including those on monotherapy or combination therapy with other lipid-altering drugs.", "effective_dosage": "25 mg, 50 mg, and 100 mg daily.", "study_duration": "6 to 96 weeks.", "interactions": "Coadministration with statins was studied.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:29.323460+00:00"}
{"study_id": 105783, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of DPP-IV inhibitors, including those targeting alanine, in extending the therapeutic effects of GLP-1 for type 2 diabetes treatment.", "results_summary": "The study highlights that DPP-IV inhibitors, which target alanine among other substrates, can prolong GLP-1's beneficial effects, enhancing insulin secretion and glucose regulation in type 2 diabetes. However, selectivity over related peptidases like DPP8 and DPP9 is critical to avoid toxicity.", "population_specificity": "Patients with type 2 diabetes (clinical studies mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:29.599180+00:00"}
{"study_id": 105785, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the therapeutic effects of intensive insulin therapy, including its impact on alanine aminotransferase (ALT) levels, in patients with traumatic shock combined with multiple organ dysfunction syndrome (MODS).", "results_summary": "Intensive insulin therapy significantly reduced ALT levels (P<0.05) alongside other markers like WBC counts, SCr, and PT, while increasing serum albumin and PaO2. It also decreased the incidence of gastrointestinal dysfunction, MODS, hospital stay, and mortality.", "population_specificity": "114 patients with traumatic shock combined with MODS.", "effective_dosage": "Continuous insulin pumping to maintain blood glucose at 4.4-6.1 mmol/L.", "study_duration": "Measurements taken at day 1, 3, 5, 7, and 14 after treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:30.189358+00:00"}
{"study_id": 105784, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to analyze the relationship between anxiety and immune markers (CD4(+) and CD4(+)/CD8(+) ratio) in chronic hepatitis B (CHB) patients and evaluate the effect of Chinese medicine (CM) combined with lamivudine on anxiety and immune function.", "results_summary": "The study found that anxiety in CHB patients was negatively correlated with CD4(+) levels and CD4(+)/CD8(+) ratio. CM combined with lamivudine significantly improved anxiety, increased CD4(+) levels and CD4(+)/CD8(+) ratio, and enhanced alanine transaminase recovery and HBV-DNA-negative conversion rates compared to lamivudine alone.", "population_specificity": "120 chronic hepatitis B (CHB) patients, with 63 classified as having anxiety (HAMA score \u226514).", "effective_dosage": "Lamivudine (100 mg per day) with or without CM based on syndrome differentiation.", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:31.794687+00:00"}
{"study_id": 105786, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of probiotic Lactobacillus rhamnosus strain GG on hypertransaminasemia (elevated alanine aminotransferase levels) in obese children with liver disease.", "results_summary": "Probiotic treatment significantly reduced alanine aminotransferase levels and antipeptidoglycan-polysaccharide antibodies, independent of changes in BMI or visceral fat. Tumor necrosis factor-alpha and ultrasonographic liver parameters remained stable.", "population_specificity": "Obese children (average age 10.7 years) with hypertransaminasemia and ultrasonographic bright liver.", "effective_dosage": "12 billion CFU/day of Lactobacillus rhamnosus strain GG.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:32.393832+00:00"}
{"study_id": 105787, "supplement_id": 863, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine if glutamine-enriched TPN (containing l-alanine-glutamine dipeptide) reduces mucositis severity and post-transplant complications in children undergoing allogeneic HSCT.", "results_summary": "The study found no significant difference in mucositis occurrence, clinical outcomes, or complications between the standard TPN and glutamine-enriched TPN groups. The intervention did not affect mucositis or overall post-transplant outcomes.", "population_specificity": "Children (median age 8.1 years) undergoing allogeneic hematopoietic stem-cell transplantation for malignant hematological diseases.", "effective_dosage": "0.4 g/kg/day of l-alanine-glutamine dipeptide.", "study_duration": "Mean duration was 23.5 days in the standard TPN group and 23 days in the glutamine-enriched TPN group.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:34.569035+00:00"}
{"study_id": 105790, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 45, "study_goal": "The researchers aimed to investigate the role of alanine aminotransferase and other markers in sickle cell trait-related micro-occlusive crisis and sudden death.", "results_summary": "The study found elevated alanine aminotransferase levels in cases of sickle cell trait-related micro-occlusive crisis, often accompanied by metabolic acidosis and myoglobinemia, but clinicians failed to diagnose the underlying cause.", "population_specificity": "16 carriers of hemoglobin S (HbS) who died under various circumstances.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:36.978719+00:00"}
{"study_id": 105791, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 76, "quality_score": 85, "study_goal": "The researchers aimed to compare the 2-year outcomes of continuing entecavir versus switching to lamivudine in patients with undetectable viral load and normal ALT after initial entecavir treatment.", "results_summary": "At 96 weeks, 76% of patients in the lamivudine arm maintained undetectable HBV DNA, compared to 100% in the entecavir arm. Virological rebound occurred in 24% of lamivudine-treated patients, with some developing drug-resistant mutations.", "population_specificity": "Patients with undetectable HBV DNA and normal ALT after at least 6 months of entecavir treatment.", "effective_dosage": "Not specified", "study_duration": "96 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:37.869447+00:00"}
{"study_id": 105788, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were investigating the maximum-tolerated dose and recommended dose of bi-weekly docetaxel in patients with advanced gastric cancer, including monitoring for adverse effects like alanine aminotransferase elevation.", "results_summary": "The study found Grade 3 alanine aminotransferase elevation in one patient at the highest dose level (50 mg/m\u00b2), indicating potential liver toxicity at that dosage. No other significant alanine-related adverse effects were reported.", "population_specificity": "Patients with advanced gastric cancer who had received prior chemotherapy.", "effective_dosage": "Docetaxel doses ranged from 35 mg/m\u00b2 to 50 mg/m\u00b2, administered every 2 weeks.", "study_duration": "At least two cycles of therapy (duration per cycle not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:37.887071+00:00"}
{"study_id": 105789, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the association between serum galectin-3 levels and clinical outcomes, including liver stiffness and function, in postoperative biliary atresia patients, with a focus on alanine aminotransferase (ALT) levels as a marker of liver injury.", "results_summary": "The study found that BA patients with elevated ALT levels had significantly higher serum galectin-3 levels compared to those with normal ALT, suggesting a link between galectin-3 and liver dysfunction. Higher galectin-3 levels were also associated with worse clinical outcomes, such as jaundice and portal hypertension.", "population_specificity": "58 postoperative biliary atresia patients and 20 healthy controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:37.938562+00:00"}
{"study_id": 105792, "supplement_id": 863, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to investigate the long-term efficacy and safety of telbivudine in patients with chronic hepatitis B (CHB), focusing on viral suppression and ALT normalization.", "results_summary": "Telbivudine demonstrated high rates of viral suppression (77% in HBeAg-positive, 85% in HBeAg-negative patients) and ALT normalization (83% in HBeAg-negative patients), with sustained HBeAg seroconversion in 84% of patients off therapy. Resistance rates were low (3.6-11.3%), and the safety profile remained favorable over three years.", "population_specificity": "HBeAg-positive (n=213) and HBeAg-negative (n=186) patients with chronic hepatitis B.", "effective_dosage": "Not specified in the abstract.", "study_duration": "3 years of treatment, with additional 52-week follow-up for some patients.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:40.141053+00:00"}
{"study_id": 105793, "supplement_id": 863, "safety_score": "45", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to investigate the safety profile of MP4OX (which includes alanine aminotransferase elevations) and its efficacy in preventing hypotensive episodes during hip arthroplasty.", "results_summary": "MP4OX significantly reduced hypotensive episodes compared to controls but had a higher rate of adverse events, including transient elevations in alanine aminotransferase and other laboratory values.", "population_specificity": "Patients undergoing elective primary hip arthroplasty with spinal anesthesia (n = 367).", "effective_dosage": "250-ml dose at induction of spinal anesthesia and a second 250-ml dose if predefined blood pressure triggers were met.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:41.907447+00:00"}
{"study_id": 105794, "supplement_id": 863, "safety_score": "70", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy and tolerability of once-daily versus twice-daily nevirapine-based HAART in virologically suppressed HIV-positive patients switched from protease inhibitor-based HAART.", "results_summary": "The study found no significant differences between once-daily and twice-daily nevirapine in terms of virological failures or tolerability/toxicity. Mean ALT and \u03b3-GT levels increased significantly overall, but there were no differences between the two dosing groups.", "population_specificity": "Virologically suppressed, HIV-positive patients previously on protease inhibitor-based HAART.", "effective_dosage": "200 mg BID for 2 months, then randomized to 200 mg BID (group A) or 400 mg QD (group B) for 10 months.", "study_duration": "12 months total (2 months initial, 10 months randomized).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:41.945838+00:00"}
{"study_id": 105796, "supplement_id": 863, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy and safety of rosiglitazone treatment in nondiabetic subjects with nonalcoholic fatty liver disease (NAFLD).", "results_summary": "Rosiglitazone treatment significantly improved liver function (reduced liver enzymes) and insulin sensitivity (decreased plasma insulin levels and homeostatic model assessment index) without adverse effects on lipid profile or body weight. No adverse events were reported.", "population_specificity": "Nondiabetic subjects with biopsy-confirmed NAFLD (mean age 44 \u00b1 11 years, BMI 29.2 \u00b1 3.1 kg/m\u00b2).", "effective_dosage": "4 mg daily", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:44.892426+00:00"}
{"study_id": 105795, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of interferon alpha and long-term lamivudine therapy in children with chronic hepatitis B, including the role of alanine aminotransferase (ALT) normalization as a marker.", "results_summary": "The study found that ALT normalization occurred in 71.1% of patients, but breakthrough and YMDD mutant rates were high (65.8% and 55.2%, respectively). Complete response was achieved in 34.2% of patients, with most responders showing results within 18 months.", "population_specificity": "HBeAg-positive children with chronic hepatitis B.", "effective_dosage": "Lamivudine (4 mg/kg/day) and interferon alpha2a (5 MU/m2 to 10 MU/m2).", "study_duration": "Lamivudine was administered until anti-HBe seroconversion and continued for six months in responders; interferon alpha2a was given for six months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:45.067169+00:00"}
{"study_id": 105797, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the regulatory mechanisms of yeast and mammalian MAF1 by the TOR pathway and assess the role of alanine replacement in Pol III transcription repression.", "results_summary": "Replacement of phosphosites with alanine decreased Pol III transcription, with a more pronounced effect in human MAF1 than yeast Maf1. Pol III repression was further enhanced by rapamycin treatment or serum starvation in mammalian cells, suggesting TOR pathway control linked to MAF1 presence.", "population_specificity": "Not specified (cellular/molecular study, not human or animal subjects).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:45.734913+00:00"}
{"study_id": 105798, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare the treatment response and safety parameters of modafinil/armodafinil for fatigue in HIV-positive patients, including those co-infected with HCV, but did not specifically focus on Alanine.", "results_summary": "The study found no change in alanine transaminase levels for HCV-positive patients, but the primary focus was on fatigue response rates and viral load changes, not Alanine's effects.", "population_specificity": "HIV-positive patients with fatigue, including 36 co-infected with HCV.", "effective_dosage": "Not mentioned", "study_duration": "12 and 26 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:45.921238+00:00"}
{"study_id": 105799, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine the relationship between pharmacokinetic parameters (including serum alanine aminotransferase) and outcomes in children with acute lymphoblastic leukemia (ALL) receiving high-dose methotrexate (HDMTX).", "results_summary": "The study found that body weight was the most significant factor for dose normalization of methotrexate, improving pharmacokinetic predictability and potentially outcomes. Higher weight was associated with worse outcomes in standard and intermediate risk groups.", "population_specificity": "304 children with acute lymphoblastic leukemia (ALL).", "effective_dosage": "Not specified (high-dose methotrexate, exact dosage not mentioned).", "study_duration": "Not specified (1284 HDMTX courses analyzed, but individual duration not stated).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:47.263895+00:00"}
{"study_id": 105800, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare clinical characteristics and viral dominance patterns between HBV/HCV dual-infected and HBV-monoinfected patients, including the role of alanine aminotransferase (ALT) levels.", "results_summary": "The study found no significant difference in ALT levels between dual-infected and monoinfected patients. HBV/HCV dual-infected patients exhibited little codominance, with either HBV or HCV dominance observed. Asian ethnicity was a major predictor of HBV-dominant disease.", "population_specificity": "115 HBV/HCV dual-infected patients and 115 HBV-monoinfected patients, matched by age, sex, ethnicity (83% Asian), and study site.", "effective_dosage": "Not specified", "study_duration": "Median follow-up times were 33 months for dual-infected and 38 months for monoinfected groups.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:49.425457+00:00"}
{"study_id": 105801, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of alanine aminotransferase (ALT) normalization as a marker for treatment response in hepatitis B.", "results_summary": "The study found that normalization of ALT levels is one of the key indicators of treatment response in hepatitis B, alongside HBV DNA suppression and seroconversion. It emphasizes monitoring ALT levels to determine when treatment should be initiated or adjusted.", "population_specificity": "Patients with hepatitis B, particularly those with high HBV replication and active or advanced liver disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:49.509677+00:00"}
{"study_id": 105802, "supplement_id": 863, "safety_score": "20", "efficacy_score": 10, "quality_score": 65, "study_goal": "The researchers assessed the efficacy and toxicity of cediranib, noting elevated alanine aminotransferase as an adverse event, but did not specifically study alanine's safety or efficacy.", "results_summary": "Elevated alanine aminotransferase was reported in 18% of patients as an adverse event, but the study did not evaluate alanine's direct effects or benefits. The primary focus was on cediranib's outcomes in HCC patients.", "population_specificity": "Patients with unresectable or metastatic hepatocellular carcinoma (HCC).", "effective_dosage": "Not Assessed", "study_duration": "28-day cycles (specific total duration not stated).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:50.002218+00:00"}
{"study_id": 105804, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to understand the pathogenesis of HEV infection, particularly the role of alanine aminotransferase activity in liver lesions and the immune response.", "results_summary": "The study found that peak liver lesions, indicated by elevated alanine aminotransferase activity, coincided with virus disappearance from stool during immune response. Non-human primates were the primary models used, with other animals also studied for HEV infection aspects.", "population_specificity": "Non-human primates (chimpanzees, rhesus, and cynomolgus macaques), pigs, rabbits, and chickens.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:53.232513+00:00"}
{"study_id": 105805, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of metformin on arterial properties, metabolic parameters, and liver function, including alanine aminotransferase levels, in patients with NAFLD.", "results_summary": "Metformin treatment significantly decreased alanine aminotransferase levels and marginally increased serum adiponectin, indicating potential liver function improvement. No significant changes in alanine aminotransferase were observed in the placebo group.", "population_specificity": "63 patients with nonalcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified (daily metformin).", "study_duration": "4 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:53.538853+00:00"}
{"study_id": 105806, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine the role of AFP-L3 as a prognostic factor in hepatocellular carcinoma (HCC) patients with low AFP levels (\u2264 20 ng/mL), not specifically focusing on alanine.", "results_summary": "The study found that AFP-L3 positivity (\u2265 10%) was associated with poorer survival in HCC patients with low AFP levels, and high AFP-L3 was identified as a significant risk factor for survival. Low alanine aminotransferase was observed in the high AFP-L3 group, but the study did not focus on alanine's effects.", "population_specificity": "196 newly diagnosed HCC patients with low AFP levels (\u2264 20 ng/mL).", "effective_dosage": "Not applicable", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:54.726798+00:00"}
{"study_id": 105803, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the role of ozone therapy in reducing HCV RNA load and its effect on liver enzymes, including alanine transaminase (ALT), in patients with chronic hepatitis C.", "results_summary": "Ozone therapy significantly improved clinical symptoms, normalized ALT and AST levels in 57.5% and 60% of patients, respectively, and resulted in negative HCV RNA PCR in 25%-45% of patients after 30-60 sessions.", "population_specificity": "52 patients with chronic hepatitis C (positive PCR for HCV RNA and elevated ALT for over 6 months).", "effective_dosage": "Not specified (major autohemotherapy, minor autohemotherapy, and rectal ozone insufflation).", "study_duration": "Up to 60 sessions (duration per session not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:54.969688+00:00"}
{"study_id": 105807, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to compare the short-term hepatic effects of two different intravenous lipid emulsions (MCT/LCT physical mixture vs. a four-component emulsion) in postoperative patients, including monitoring alanine aminotransferase levels.", "results_summary": "The study found no significant changes in alanine aminotransferase levels during the 5-day observation period, though gamma-glutamyl transferase (GGT) activity increased significantly, indicating cholestatic-type hepatobiliary deviations without clinical impact.", "population_specificity": "Patients undergoing elective gastrointestinal surgery in the early postoperative period.", "effective_dosage": "Not specified", "study_duration": "5 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:55.149387+00:00"}
{"study_id": 105809, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were not attempting to determine anything about Alanine; the study focused on the effectiveness and safety of infliximab for Crohn's disease.", "results_summary": "The study did not investigate Alanine's effects; it reported on infliximab's impact on Crohn's disease symptoms and biomarkers.", "population_specificity": "Chinese patients with active Crohn's disease.", "effective_dosage": "Not applicable (study used infliximab, not Alanine).", "study_duration": "Not applicable (study duration was 14 weeks for infliximab).", "interactions": "None mentioned (study did not assess Alanine).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:44:58.680268+00:00"}
{"study_id": 105810, "supplement_id": 863, "safety_score": "70", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the efficacy and tolerability of a fenofibrate/pravastatin fixed-dose combination (FDC) versus simvastatin monotherapy in patients with type 2 diabetes and mixed hyperlipidemia, focusing on lipid parameters and safety, including alanine aminotransferase (ALT) levels.", "results_summary": "The FDC significantly improved non-HDL-C, triglyceride, and HDL-C levels compared to simvastatin monotherapy but was associated with greater increases in ALT, creatinine, and homocysteine concentrations. Both treatments were well tolerated, with no significant difference in adverse event prevalence.", "population_specificity": "Adults with type 2 diabetes and mixed hyperlipidemia, without cardiovascular disease, who did not achieve lipid goals on simvastatin 20 mg monotherapy.", "effective_dosage": "Fenofibrate/pravastatin 160/40 mg FDC once daily.", "study_duration": "12-week treatment period followed by a 12-week open-label tolerability-assessment period.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:00.282795+00:00"}
{"study_id": 105811, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to identify risk factors for hepatocellular carcinoma (HCC) in primary biliary cirrhosis (PBC) patients treated with ursodeoxycholic acid (UDCA) and determine if a subgroup could benefit from HCC screening.", "results_summary": "The study found that the risk of HCC in UDCA-treated PBC patients was relatively low (0.2% annual incidence), with non-response to UDCA being the main risk factor (9% 10-year and 20% 15-year incidence).", "population_specificity": "Patients with primary biliary cirrhosis (PBC) treated with UDCA.", "effective_dosage": "13-15 mg/kg/day UDCA.", "study_duration": "Median follow-up of 9.7 years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:02.081842+00:00"}
{"study_id": 105812, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the relationship between high-level coffee consumption and improved virologic response to peginterferon plus ribavirin therapy in hepatitis C patients.", "results_summary": "High coffee consumption (\u22653 cups/day) was associated with significantly improved virologic responses at weeks 12, 20, 48, and 72, with adjusted odds ratios ranging from 1.8 to 2.4 compared to non-drinkers. The strongest effect was observed at the end of treatment (OR 2.4).", "population_specificity": "Patients with hepatitis C from the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial (n=885).", "effective_dosage": "Not applicable (coffee consumption was self-reported, not standardized).", "study_duration": "Follow-up periods included weeks 12, 20, 48, and 72.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:03.119228+00:00"}
{"study_id": 105814, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare testing strategies for chronic viral hepatitis in patients with abnormal liver function tests (LFTs), including the role of alanine aminotransferase (ALT) levels in detection.", "results_summary": "The study found that a notably high ALT level (>2x upper limit of normal) had high predictive value for viral hepatitis but missed half the cases. Testing all patients from high-prevalence countries was more efficient than repeating LFTs.", "population_specificity": "Patients with abnormal LFTs and no pre-existing or self-evident liver disease.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:03.138454+00:00"}
{"study_id": 105813, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the association between IL28B polymorphisms and response to PEG-IFN/ribavirin therapy in HCV genotype 3-infected patients, including the role of alanine aminotransferase (ALT) as a marker of liver disease.", "results_summary": "The study found that IL28B polymorphisms were associated with rapid viral response but not sustained viral response in HCV genotype 3-infected patients. Additionally, responder genotypes of the SNPs rs12979860 and rs8099917 showed significant associations with high ALT levels, indicating liver disease activity.", "population_specificity": "281 patients infected with HCV genotype 3.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:03.544933+00:00"}
{"study_id": 105815, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effectiveness of dietary carbohydrate and calorie restriction on reducing hepatic triglycerides in subjects with NAFLD, with a secondary focus on changes in plasma alanine aminotransferase levels.", "results_summary": "The study found that plasma alanine aminotransferase levels did not decrease significantly with weight loss, unlike aspartate aminotransferase. Reductions in hepatic triglycerides were greater with carbohydrate restriction than calorie restriction, potentially due to enhanced oxidation.", "population_specificity": "18 subjects (5 men, 13 women) with NAFLD, mean age 45 \u00b1 12 y, BMI 35 \u00b1 7 kg/m\u00b2.", "effective_dosage": "Not specified for alanine (study focused on dietary carbohydrate restriction <20 g/d or calorie restriction 1200-1500 kcal/d).", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:05.707989+00:00"}
{"study_id": 105816, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the interpretation of serum ferritin elevation in relation to clinical parameters, including alanine aminotransferase (ALT), to guide non-invasive iron testing.", "results_summary": "The study used liver iron concentration measurements as a gold standard to assess predictive values of non-invasive iron tests, including ALT, but did not report specific findings on alanine's effects.", "population_specificity": "Patients with hepatic iron overload from two referral practices.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:06.117945+00:00"}
{"study_id": 105808, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of Alanine in the context of lipid profile changes and hepatic injury biomarkers when combined with atorvastatin in dyslipidemic subjects.", "results_summary": "Serum alanine aminotransferase levels increased significantly in the atorvastatin group but not in the H. persicum + atorvastatin group, suggesting potential hepatic effects. No significant changes were observed in other biomarkers like creatinine or fasting blood sugar.", "population_specificity": "Dyslipidemic subjects (n=100, completers=52)", "effective_dosage": "Not specified for Alanine alone (study focused on H. persicum + atorvastatin)", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:07.459483+00:00"}
{"study_id": 105817, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare risk factors between children with medication-induced diabetes and those with type 2 diabetes, including evaluating elevated alanine aminotransferase levels as a comorbidity.", "results_summary": "The study found that children with medication-induced diabetes were less likely to have elevated alanine aminotransferase levels compared to those with type 2 diabetes (P = .05). Alanine aminotransferase was noted as one of several obesity-related comorbidities.", "population_specificity": "Children aged <18 years diagnosed with medication-induced diabetes (n = 58) or type 2 diabetes (n = 225).", "effective_dosage": "Not available", "study_duration": "Data collected over a 2-year period.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:09.887228+00:00"}
{"study_id": 105819, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the 48-week efficacy of entecavir versus adefovir in HBeAg-positive nucleos(t)ide-na\u00efve Asian patients with chronic hepatitis B, focusing on serum HBV DNA suppression, ALT normalization, HBeAg clearance, and seroconversion.", "results_summary": "Entecavir was superior to adefovir in reducing serum HBV DNA and normalizing ALT levels but showed no significant difference in HBeAg clearance or seroconversion rates.", "population_specificity": "HBeAg-positive nucleos(t)ide-na\u00efve Asian patients with chronic hepatitis B.", "effective_dosage": "Not specified", "study_duration": "48 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:11.070385+00:00"}
{"study_id": 105818, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to compare blood glucose responses between critically ill surgical patients with adequate and deficient vitamin B-6 status, focusing on the role of alanine aminotransaminase activity as an indirect measure of vitamin B-6 status.", "results_summary": "Patients with adequate plasma PLP (vitamin B-6) showed improved blood glucose response by day 7, while those with deficient PLP remained hyperglycemic. Higher plasma PLP at admission correlated with reduced glucose levels in deficient patients.", "population_specificity": "Critically ill surgical patients in the intensive care unit.", "effective_dosage": "Not specified", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:11.132815+00:00"}
{"study_id": 105820, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the clinical efficacy of alanine-glutamine dipeptide-supplemented total parenteral nutrition in reducing nosocomial infections and improving glycemic control in ICU patients.", "results_summary": "The study found that alanine-glutamine supplementation reduced nosocomial pneumonia and urinary tract infections, improved glycemic control with lower insulin needs, but did not affect ICU/hospital stay or 6-month survival.", "population_specificity": "ICU patients with Acute Physiology and Chronic Health Evaluation II score >12 requiring parenteral nutrition for 5-9 days.", "effective_dosage": "0.5 g/kg/d of glutamine dipeptide.", "study_duration": "5-9 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:11.679278+00:00"}
{"study_id": 105822, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not investigate Alanine; it evaluates the efficacy and toxicity of a chemotherapy combination (paclitaxel, ifosfamide, and nedaplatin) for recurrent or metastatic urothelial cancer.", "results_summary": "The study does not report findings related to Alanine.", "population_specificity": "Patients with recurrent or metastatic urothelial cancer previously treated with methotrexate, vinblastine, doxorubicin, and cisplatin, or gemcitabine and cisplatin.", "effective_dosage": "Not applicable", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:13.200351+00:00"}
{"study_id": 105821, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the lipid-altering efficacy and safety of ezetimibe plus statin versus statin monotherapy in hypercholesterolaemic patients with and without diabetes, not specifically focusing on Alanine.", "results_summary": "The study found that ezetimibe plus statin was more effective than statin monotherapy in improving various lipid parameters, with larger reductions in LDL-C, TC, and non-HDL-C in diabetic patients. Safety profiles were similar between groups, except for a small but higher incidence of liver enzyme elevations in the ezetimibe/statin group.", "population_specificity": "Hypercholesterolaemic adults with (n = 6541) and without (n = 15253) diabetes.", "effective_dosage": "Ezetimibe 10 mg plus statin (specific statin dosage not detailed).", "study_duration": "4-24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:13.326476+00:00"}
{"study_id": 105823, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to clarify discrepancies in sarcosine's potential as a biomarker for prostate cancer detection and reevaluate its diagnostic value, including its relationship with alanine.", "results_summary": "Sarcosine algorithms, including those involving alanine, were higher in prostate cancer patients but showed no correlation with disease severity. Diagnostic power was modest compared to other biomarkers but improved when combined with PCA3 or %fPSA.", "population_specificity": "71 untreated prostate cancer patients, 39 patients with no evidence of malignancy, and 20 healthy men and women.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:14.300697+00:00"}
{"study_id": 105824, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of the rs738409 CG genotype on liver fat and fibrosis in chronic hepatitis C (CHC) patients, and its potential influence on steatosis-related complications like treatment failure and hepatocellular carcinoma (HCC).", "results_summary": "The rs738409 GG genotype was associated with increased steatosis, fibrosis, cirrhosis, treatment failure, and HCC occurrence in CHC patients, independent of confounders like BMI, diabetes, and alcohol intake.", "population_specificity": "Chronic hepatitis C patients (two independent cohorts of 325 and 494 patients) from tertiary referral centers in northern Italy.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:15.731833+00:00"}
{"study_id": 105826, "supplement_id": 863, "safety_score": "40", "efficacy_score": 20, "quality_score": 75, "study_goal": "To evaluate the efficacy, safety, and tolerability of SCIO-469, a p38 MAPK inhibitor, in patients with active rheumatoid arthritis.", "results_summary": "SCIO-469 showed no greater efficacy than placebo in treating rheumatoid arthritis. The 60 mg IR regimen exhibited dose-limiting toxicity with elevated alanine aminotransferase, and adverse events were common across all groups.", "population_specificity": "Patients with active rheumatoid arthritis.", "effective_dosage": "30 mg or 60 mg three times daily (IR), 100 mg once daily (ER).", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:19.149372+00:00"}
{"study_id": 105825, "supplement_id": 863, "safety_score": "65", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy and tolerability of MP4OX (a hemoglobin-based oxygen carrier) compared to hydroxyethyl starch (HES) in treating hypotensive episodes during and after hip arthroplasty under spinal anesthesia.", "results_summary": "MP4OX significantly reduced the total duration of hypotensive episodes compared to HES, but it was associated with higher incidences of transient lab abnormalities (e.g., alanine aminotransferase) and certain adverse events (e.g., nausea, bradycardia). No significant differences were found in serious adverse events or composite morbidity/ischemia outcomes.", "population_specificity": "Patients undergoing primary hip arthroplasty under spinal anesthesia across 21 study sites in 5 countries.", "effective_dosage": "250 mL doses (up to two doses if needed, triggered by systolic blood pressure thresholds).", "study_duration": "During surgery and the first 6 hours post-skin closure.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:19.825298+00:00"}
{"study_id": 105828, "supplement_id": 863, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety, tolerability, and antiviral efficacy of NIM811, a cyclophilin inhibitor, both as monotherapy and in combination with pegylated interferon alpha in genotype 1 HCV patients.", "results_summary": "NIM811 monotherapy normalized liver transaminases without significant virological response, while combination therapy with pegylated interferon alpha showed significant antiviral activity (2.85 log HCV RNA decline) and ALT reduction. The drug was well-tolerated, with mild bilirubin elevations and platelet declines at higher doses.", "population_specificity": "Genotype 1 HCV patients, including relapsers.", "effective_dosage": "10\u2013600 mg once or twice daily (monotherapy); 600 mg twice daily (combination therapy).", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:20.544593+00:00"}
{"study_id": 105829, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety and effectiveness of oral antivirals (TDF, FTC/TDF, ETV) in patients with chronic hepatitis B and decompensated liver disease, not specifically Alanine.", "results_summary": "The study found that all treatments were well tolerated, with infrequent tolerability failures and renal parameter issues. Virologic, biochemical, and clinical parameters improved across all groups.", "population_specificity": "Patients with chronic hepatitis B and decompensated liver disease.", "effective_dosage": "Not specified for Alanine.", "study_duration": "48 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:20.847574+00:00"}
{"study_id": 105827, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 24, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety and efficacy of peginterferon alfa-2a, with or without adefovir dipivoxil, in treating chronic hepatitis delta virus (HDV) infection, focusing on normalization of alanine aminotransferase levels and HDV RNA clearance.", "results_summary": "Peginterferon alfa-2a, with or without adefovir, led to sustained HDV RNA clearance in about 25% of patients, while adefovir alone showed no efficacy. Normalization of alanine aminotransferase levels and HDV RNA clearance at week 48 was achieved in a small fraction of patients receiving peginterferon-based treatments.", "population_specificity": "Patients with chronic HDV infection.", "effective_dosage": "180 \u03bcg of peginterferon alfa-2a weekly, with or without 10 mg of adefovir dipivoxil daily.", "study_duration": "48 weeks of treatment, with an additional 24 weeks of follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:22.228423+00:00"}
{"study_id": 105831, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of alanine transaminase monitoring and antiviral therapy in preventing HBV reactivation in immunosuppressed patients.", "results_summary": "The study highlights the importance of monitoring alanine transaminase and HBV DNA levels in anti-HBc-positive patients to detect HBV reactivation early and initiate antiviral therapy. Prophylactic lamivudine was shown to prevent reactivation, but optimal duration remains unclear.", "population_specificity": "Patients with prior HBV infection (HBsAg-positive or anti-HBc-positive) undergoing immunosuppressive therapy or organ transplantation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:22.306415+00:00"}
{"study_id": 105830, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the correlation between alanine aminotransferase (ALT) levels and hepatitis B virus (HBV) DNA in HBsAg-positive individuals, particularly focusing on HBeAg-negative patients.", "results_summary": "The study found no correlation between ALT and HBV DNA levels in HBeAg-positive patients and only a weak correlation in HBeAg-negative patients. Additionally, 35% of HBeAg-negative patients with detectable HBV DNA had normal ALT levels, while 38% with no detectable HBV DNA had elevated ALT levels.", "population_specificity": "HBsAg-positive individuals, including HBeAg-negative and HBeAg-positive patients with chronic hepatitis B.", "effective_dosage": "Not mentioned", "study_duration": "Longitudinal follow-up of 24 months for a subgroup of HBeAg-negative patients.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:23.587379+00:00"}
{"study_id": 105832, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the treatment strategies for HBeAg-negative chronic hepatitis B, focusing on the role of PEG-IFN and its impact on alanine transaminase levels and disease progression.", "results_summary": "The study found that PEG-IFN achieved a sustained virological response in about 25% of patients, with significant HBsAg seroclearance rates, but highlighted the need for careful patient selection and treatment optimization.", "population_specificity": "Patients with HBeAg-negative chronic hepatitis B.", "effective_dosage": "Not specified for alanine; PEG-IFN was administered for 1 year or up to 96 weeks in responders.", "study_duration": "1 year for standard therapy, up to 96 weeks for extended therapy.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:25.923391+00:00"}
{"study_id": 105833, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of alanine transaminase normalization as an endpoint in antiviral therapy for chronic hepatitis B infection.", "results_summary": "The study found that normalization of serum alanine transaminase is a key endpoint in antiviral therapy, indicating reduced necroinflammation and fibrosis, and contributing to clinical benefits such as reduced hepatocellular carcinoma risk.", "population_specificity": "Patients with chronic hepatitis B infection in the immune clearance phase.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:26.385302+00:00"}
{"study_id": 105835, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to determine whether DHA supplementation affects alanine transaminase levels in children with NAFLD.", "results_summary": "The study found no significant effect of DHA supplementation on alanine transaminase levels after 6 months of treatment, despite improvements in liver steatosis and insulin sensitivity.", "population_specificity": "60 children with biopsy-proven non-alcoholic fatty liver disease (NAFLD).", "effective_dosage": "250 mg/day and 500 mg/day of DHA.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:28.079573+00:00"}
{"study_id": 105834, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to compare postoperative liver injury markers in patients receiving intravenous fish oil (IFO) with PN-associated cholestasis (PNAC) versus those with resolved PNAC, focusing on alanine aminotransferase levels.", "results_summary": "Operations before PNAC resolution were associated with increased postoperative direct bilirubin (69% of cases), while post-PNAC resolution procedures had a low incidence of cholestasis recurrence (7%). The median time to return to preoperative downward DB trend was 21 days.", "population_specificity": "Patients with PN-associated cholestasis undergoing abdominal laparotomy (n=23, 27 operations).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:28.880186+00:00"}
{"study_id": 105837, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were examining the association between hepatic steatosis in chronic hepatitis C patients and factors such as alanine aminotransferase levels, but not specifically evaluating alanine as a supplement.", "results_summary": "The study found that higher serum alanine aminotransferase levels were associated with hepatic steatosis in chronic hepatitis C patients, particularly in genotype 3 infections, and correlated with hepatic fibrosis and poor treatment response.", "population_specificity": "Patients with chronic hepatitis C virus infection, particularly those with genotype 3.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:30.135883+00:00"}
{"study_id": 105836, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the diagnostic value of ultrasound elastography for measuring liver stiffness in HBV-infected patients treated with telbivudine, including the correlation between alanine aminotransferase (ALT) and liver stiffness.", "results_summary": "The study found that liver stiffness decreased significantly in chronic HBV patients after telbivudine treatment, with higher stiffness in decompensated cirrhosis patients. ALT did not significantly correlate with liver stiffness, unlike fibrosis indices and hyaluronic acid levels.", "population_specificity": "74 patients with HBV infection (22 chronic HBV, 32 compensated cirrhosis, 20 decompensated cirrhosis).", "effective_dosage": "600 mg telbivudine orally once daily.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:30.327425+00:00"}
{"study_id": 105838, "supplement_id": 863, "safety_score": "65", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy, safety, tolerability, and pharmacokinetics of BIBF 1120 (which includes alanine transaminase effects) in patients with advanced non-small-cell lung cancer.", "results_summary": "The study found that BIBF 1120 was well tolerated, with common adverse events including nausea, diarrhea, and reversible alanine transaminase elevations. Tumor stabilization was achieved in 46% of patients, but efficacy was modest with a median progression-free survival of 6.9 weeks.", "population_specificity": "Patients with stage IIIB/IV non-small-cell lung cancer who failed first- or second-line platinum-based chemotherapy.", "effective_dosage": "250 mg b.i.d. or 150 mg b.i.d.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:31.194399+00:00"}
{"study_id": 105839, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers were investigating the efficacy and safety of adding iniparib (a PARP inhibitor) to gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer, not specifically studying alanine.", "results_summary": "The study found that increased alanine aminotransferase levels were among the most frequent grade 3 or 4 adverse events, but the abstract does not focus on alanine's effects.", "population_specificity": "Patients with metastatic triple-negative breast cancer (n=123).", "effective_dosage": "Not specified for alanine.", "study_duration": "Treatment cycles were every 21 days, but total duration is not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:32.007382+00:00"}
{"study_id": 105840, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to study the genotypes and phenotypes of patients with ferroportin disease, including the correlation between transferrin saturation and alanine aminotransferase levels as potential markers of disease severity.", "results_summary": "The study found that transferrin saturation correlated with fibrosis and alanine aminotransferase levels, suggesting it might be a marker of disease severity in ferroportin disease. No direct effects of alanine supplementation or its role in the disease were assessed.", "population_specificity": "70 affected subjects from 33 families with ferroportin disease and 19 mutations.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:33.992186+00:00"}
{"study_id": 105842, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to develop computational algorithms to identify sequence and structural requirements for substrate recognition by chaperones, using techniques like alanine scanning mutagenesis.", "results_summary": "The study presented computational tools to screen potential substrates for chaperone recognition, leveraging methods such as alanine scanning mutagenesis, but did not report specific findings on alanine's effects.", "population_specificity": "Not specified (computational study)", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:35.261534+00:00"}
{"study_id": 105841, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare treatment options for chronic hepatitis B (CHB), focusing on nucleos(t)ide analogues versus peginterferon (PEG-IFN), and assess predictors of response, including alanine aminotransferase levels.", "results_summary": "The study found that nucleos(t)ide analogues (entecavir and tenofovir) effectively suppress HBV DNA long-term but require prolonged therapy, while PEG-IFN offers sustained response in select patients but has frequent side effects. Pre-treatment markers like alanine aminotransferase and HBV DNA levels help identify suitable candidates for PEG-IFN.", "population_specificity": "Patients with chronic hepatitis B (CHB).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:35.682265+00:00"}
{"study_id": 105843, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate early biological changes, including Alanine-related biomarkers, in synovial fluid and serum after acute knee injury to understand post-traumatic osteoarthritis development.", "results_summary": "The study found significant decreases in synovial fluid Alanine-Arginine-Glycine-Serine (ARGS) aggrecan (P = 0.004), indicating proteoglycan loss, alongside increases in collagen biomarkers, suggesting early cartilage degradation post-injury.", "population_specificity": "Individuals younger than 40 years with acute knee injury and no pre-existing osteoarthritis or prior joint symptoms.", "effective_dosage": "Not specified", "study_duration": "Mean follow-up of 47.6 \u00b1 12.4 days post-injury", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:37.568542+00:00"}
{"study_id": 105844, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to identify factors influencing Alanine Aminotransferase (ALT) levels and establish mean ALT levels among healthy medical students.", "results_summary": "The study found a significant sex difference in ALT levels (higher in men) and a positive correlation between ALT levels and BMI. No significant variation was observed among different ethnic groups.", "population_specificity": "143 healthy medical students (93 men, 50 women) aged 18-22 years from Army Medical College, National University of Sciences and Technology.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:38.405603+00:00"}
{"study_id": 109482, "supplement_id": 881, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to explore the potential role of antioxidants in managing pain induced by chronic pancreatitis.", "results_summary": "The abstract mentions antioxidants as one of several treatment possibilities for pain management in chronic pancreatitis, but no specific efficacy data or outcomes are provided.", "population_specificity": "Patients with chronic pancreatitis experiencing pain.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:45:44.653897+00:00"}
